Search for a doctor

Raymund R. Razonable, M.D.

  1. Infectious Disease Specialist
  2. Vice Chair, Infectious Diseases, Minnesota
Request an Appointment

Publications

  1. Khodadadi RB, Yetmar ZA, Domonoske CL, Razonable RR. Factors associated with infectious diseases fellowship academic success. Med Educ Online. 2024 Dec 31; 29 (1):2352953 Epub 2024 May 08
    View PubMed
  2. Razonable RR. Pathogen-specific cell-mediated immunity to guide the management of cytomegalovirus in solid organ transplantation: state of the art clinical review. Expert Rev Clin Immunol. 2024 Nov; 20 (11):1367-1380 Epub 2024 July 24
    View PubMed
  3. Non LR, Tan CS, Ince D, Razonable RR. Survey of Post-Prophylaxis Delayed-Onset Cytomegalovirus Management Strategies Among Transplant Providers. Clin Transplant. 2024 Nov; 38 (11):e70015
    View PubMed
  4. Grant LM, Vega PJT, Yaman RN, Girardo ME, Beam E, Razonable RR, Saling CF, Vikram HR. Brain abscess following solid organ transplantation: A 21-year retrospective study. Transpl Infect Dis. 2024 Oct 13; e14394 [Epub ahead of print]
    View PubMed
  5. Moynan D, Higgins E, Passerini M, Prokop LJ, Murad MH, Razonable RR. Secondary anti-viral prophylaxis in solid organ transplant recipients for the prevention of cytomegalovirus relapse: A systematic review and meta-analysis. Transpl Infect Dis. 2024 Oct 13; e14393 [Epub ahead of print]
    View PubMed
  6. Mendoza MA, Bhaimia E, Alkhateeb HB, Razonable RR, Thoendel M. Which allogeneic hematopoietic cell transplant recipients have an increased risk for delayed-onset clinically significant cytomegalovirus infection after letermovir prophylaxis? Transpl Infect Dis. 2024 Sep 28; e14377 Epub 2024 Sept 28
    View PubMed
  7. Ljungman P, Chemaly RF, Khawaya F, Alain S, Avery R, Badshah C, Boeckh M, Fournier M, Hodowanec A, Komatsu T, Limaye AP, Manuel O, Natori Y, Navarro D, Pikis A, Razonable RR, Westman G, Miller V, Griffiths PD, Kotton CN, CMV Definitions Working Group of the Transplant Associated Virus Infections Forum. Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum. Clin Infect Dis. 2024 Sep 26; 79 (3):787-794
    View PubMed
  8. Zamora D, Dasgupta S, Stevens-Ayers T, Edmison B, Winston DJ, Razonable RR, Mehta AK, Lyon GM, Boeckh M, Singh N, Koelle DM, Limaye AP. Cytomegalovirus immunity in high-risk liver transplant recipients following preemptive antiviral therapy versus prophylaxis. JCI Insight. 2024 Sep 24; 9 (18) Epub 2024 Sept 24
    View PubMed
  9. Wahab A, Sanborn D, Vergidis P, Razonable R, Razonazole R, Yadav H, Pennington KM. Diagnosis and Prevention of Invasive Fungal Infections in the Immunocompromised Host. Chest. 2024 Sep 7 Epub 2024 Sept 07
    View PubMed
  10. Pham JH, Razonable RR. Management of resistant and refractory cytomegalovirus infections after transplantation. Expert Rev Anti Infect Ther. 2024 Sep 5; 1-12 Epub 2024 Sept 05
    View PubMed
  11. Chesdachai S, Rivera CG, Rosedahl JK, Philpot LM, Dholakia R, Borah BJ, Draper EW, Arndt R, Ganesh R, Larsen JJ, Destro Borgen MJ, Razonable RR. Outpatient remdesivir treatment program for hospitalized patients with coronavirus disease-2019: Patient perceptions, process and economic impact. Healthc (Amst). 2024 Aug 13; 12 (4):100750 [Epub ahead of print]
    View PubMed
  12. Ripoll JG, Tulledge-Scheitel SM, Stephenson AA, Ford S, Pike ML, Gorman EK, Hanson SN, Juskewitch JE, Miller AJ, Zaremba S, Ovrom EA, Razonable RR, Ganesh R, Hurt RT, Fischer EN, Derr AN, Eberle MR, Larsen JJ, Carney CM, Theel ES, Parikh SA, Kay NE, Joyner MJ, Senefeld JW. Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19. mBio. 2024 May 8; 15 (5):e0040024 Epub 2024 Apr 11
    View PubMed
  13. Hosseini-Moghaddam SM, Kothari S, Humar A, Albasata H, Yetmar ZA, Razonable RR, Neofytos D, D'Asaro M, Boggian K, Hirzel C, Khanna N, Manuel O, Mueller NJ, Imlay H, Kabbani D, Tyagi V, Smibert OC, Nasra M, Fontana L, Obeid KM, Apostolopoulou A, Zhang SX, Permpalung N, Alhatimi H, Silverman MS, Guo H, Rogers BA, MacKenzie E, Pisano J, Gioia F, Rapi L, Prasad GVR, Banegas M, Alonso CD, Doss K, Rakita RM, Fishman JA. Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020. Am J Transplant. 2024 Apr; 24 (4):653-668 Epub 2023 Nov 17
    View PubMed
  14. Pennington KM, Martin MJ, Murad MH, Sanborn D, Saddoughi SA, Gerberi D, Peters SG, Razonable RR, Kennedy CC. Risk Factors for Early Fungal Disease in Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis. Transplantation. 2024 Apr 1; 108 (4):970-984 Epub 2023 Nov 13
    View PubMed
  15. Friedman DZP, Theel ES, Walker RC, Vikram HR, Razonable RR, Vergidis P. Serial Bronchoalveolar Lavage Fluid Aspergillus Galactomannan and Treatment Response in Invasive Pulmonary Aspergillosis. Open Forum Infect Dis. 2024 Apr; 11 (4):ofae114 Epub 2024 Mar 01
    View PubMed
  16. Chesdachai S, Rivera CG, Cole KC, Teaford HR, Gonzalez Suarez ML, Larsen JJ, Ganesh R, Tulledge-Scheitel S, Razonable RR. Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID-19 during the omicron BA.1 surge. Sci Rep. 2024 Mar 5; 14 (1):5430 Epub 2024 Mar 05
    View PubMed
  17. Ordaya EE, Razonable RR. Emerging anti-spike monoclonal antibodies against SARS-CoV-2. Expert Opin Biol Ther. 2024 Mar; 24 (3):191-201 Epub 2024 Mar 26
    View PubMed
  18. Luther VP, Paras ML, Schultz S, Aziz M, Balba G, McCarty TP, Razonable RR, Reece R, Shnekendorf R, Sundareshan V, Chirch LM, Infectious Diseases Society of America Infectious Diseases Training Program Directors Committee and Working Group. High-Volume, High-Acuity, and High-Impact Learning: Tips and Tricks for Infectious Diseases Training Programs. Open Forum Infect Dis. 2024 Mar; 11 (3):ofae016 Epub 2024 Jan 08
    View PubMed
  19. Abad CLR, Razonable RR. Clinical Characteristics and Outcomes of Endemic Mycoses After Solid Organ Transplantation: A Comprehensive Review. Open Forum Infect Dis. 2024 Mar; 11 (3):ofae036 Epub 2024 Jan 22
    View PubMed
  20. Yetmar ZA, Kudva YC, Seville MT, Bosch W, Huskey JL, Jarmi T, Kukla A, Dean PG, Razonable RR, Beam E. Risk of cytomegalovirus infection and subsequent allograft failure after pancreas transplantation. Am J Transplant. 2024 Feb; 24 (2):271-279 Epub 2023 Oct 13
    View PubMed
  21. Abad CLR, Razonable RR. Donor-derived endemic mycoses after solid organ transplantation: A review of reported cases. Clin Transplant. 2024 Jan; 38 (1):e15199 Epub 2023 Nov 22
    View PubMed
  22. Ganesh R, Yadav S, Hurt RT, Mueller MR, Aakre CA, Gilman EA, Grach SL, Overgaard J, Snyder MR, Collins NM, Croghan IT, Badley AD, Razonable RR, Salonen BR. Pro Inflammatory Cytokines Profiles of Patients With Long COVID Differ Between Variant Epochs. J Prim Care Community Health. 2024 Jan-Dec; 15:21501319241254751
    View PubMed
  23. Razonable RR. Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity. Front Immunol. 2024; 15:1397040 Epub 2024 May 02
    View PubMed
  24. Razonable RR. Current Perspectives on Letermovir and Maribavir for the Management of Cytomegalovirus Infection in Solid Organ Transplant Recipients. Drug Des Devel Ther. 2024; 18:3987-4001 Epub 2024 Sept 06
    View PubMed
  25. Gonzalez Suarez ML, Mara KC, Rivera CG, Chesdachai S, Draper E, Razonable RR. Association of renal function with mortality among hospitalized patients treated with remdesivir for COVID-19. PLoS One. 2024; 19 (6):e0303896 Epub 2024 June 14
    View PubMed
  26. Bell CF, Gibbons DC, Drysdale M, Birch HJ, Lloyd EJ, Patel V, Carpenter C, Carlson K, Calay ES, Puranik A, Wagner TE, O'Horo JC, Razonable RR. Real-world effectiveness of sotrovimab in preventing hospitalization and mortality in high-risk patients with COVID-19 in the United States: A cohort study from the Mayo Clinic electronic health records. PLoS One. 2024; 19 (7):e0304822 Epub 2024 July 16
    View PubMed
  27. Razonable RR. Corrigendum: Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity. Front Immunol. 2024; 15:1440571 Epub 2024 July 25
    View PubMed
  28. Gupta S, Grant LM, Powers HR, Kimes KE, Hamdi A, Butterfield RJ, Gea-Banacloche J, Vijayvargiya P, Hata DJ, Meza Villegas DM, Dumitrascu AC, Harris DM, Chirila RM, Zhang N, Razonable RR, Kusne S, Alvarez S, Vikram HR. Invasive Nocardia Infections across Distinct Geographic Regions, United States. Emerg Infect Dis. 2023 Dec; 29(12):2417-25.
    View PubMed
  29. Kasten MJ, Lahr BD, Parisapogu A, Yetmar ZA, O'Horo JC, Orenstein R, Moreno Franco P, Razonable RR, Vergidis P, Shah AS, Enzler MJ, Inwards DJ, Bauer PR. COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients. Sci Rep. 2023 Dec 1; 13 (1):21249 Epub 2023 Dec 01
    View PubMed
  30. Higgins E, Ranganath N, Mehkri O, Majeed A, Walker J, Spivack S, Bhaimia E, Benamu E, Hand J, Keswani S, Dunn D, Beam E, Razonable RR. Clinical features, treatment, and outcomes of mpox in solid organ transplant recipients: A multicenter case series and literature review. Am J Transplant. 2023 Dec; 23 (12):1972-1979 Epub 2023 July 27
    View PubMed
  31. Abad CLR, Razonable RR. A review of endemic mycoses after hematopoietic stem cell transplantation. Transpl Infect Dis. 2023 Dec; 25 (6):e14155 Epub 2023 Sept 14
    View PubMed
  32. Ambrose N, Amin A, Anderson B, Bertagnolli M, Campion F, Chow D, Danan R, D'Arinzo L, Drews A, Erlandson K, Fitzgerald K, Gaspar F, Gong C, Hanna G, Hawley H, Jones S, Lopansri B, Mullen T, Musser J, O'Horo J, Piantadosi S, Pritt B, Razonable R, Rele S, Roberts S, Sandmeyer S, Stein D, Te J, Vahidy F, Webb B, Welch N, Wood A, Yttri J. The Influence of Social Determinants on Receiving Outpatient Treatment with Monoclonal Antibodies, Disease Risk, and Effectiveness for COVID-19. J Gen Intern Med. 2023 Dec; 38 (16):3472-3481 Epub 2023 Sept 15
    View PubMed
  33. Dioverti MV, Bhaimia E, Yetmar ZA, Melendez DP, Misner L, Beito E, Deziel PJ, Theel ES, Razonable RR. Clinical utility of a cytomegalovirus-specific T cell assay in assessing the risk of post-prophylaxis cytomegalovirus infection and post-treatment relapse. Clin Transplant. 2023 Dec; 37 (12):e15143 Epub 2023 Oct 08
    View PubMed
  34. Streck NT, Espy MJ, Ferber MJ, Klee EW, Razonable RR, Gonzalez D, Sayada C, Heaton PR, Chou S, Binnicker MJ. Use of next-generation sequencing to detect mutations associated with antiviral drug resistance in cytomegalovirus. J Clin Microbiol. 2023 Oct 24; 61 (10):e0042923 Epub 2023 Sept 26
    View PubMed
  35. Blumberg EA, Nam HH, Covington S, Danziger-Isakov L, Kumar D, Michaels MG, Razonable RR, Pereira MR. Into the unknown: The end of the coronavirus disease 2019 public health emergency in the United States and potential impacts on organ transplant recipients. Am J Transplant. 2023 Oct; 23 (10):1507-1510 Epub 2023 July 20
    View PubMed
  36. Chesdachai S, Yetmar ZA, Mendoza MA, Ranganath N, Schettle SD, Boilson BA, Shah AS, Razonable RR. Clinical Characteristics and Outcomes of Clostridioides difficile Infection in Patients With Left Ventricular Assist Device. ASAIO J. 2023 Oct 1; 69 (10):950-955 Epub 2023 June 27
    View PubMed
  37. Razonable RR. Oral antiviral drugs for treatment of cytomegalovirus in transplant recipients. Clin Microbiol Infect. 2023 Sep; 29 (9):1144-1149 Epub 2023 Mar 23
    View PubMed
  38. Mendoza MA, Razonable RR. Coronavirus Disease 2019 Management Strategies in Solid Organ Transplant Recipients. Infect Dis Clin North Am. 2023 Sep; 37 (3):475-493 Epub 2023 Mar 21
    View PubMed
  39. Abad CLR, Razonable RR. Multi-drug resistant and rifampin-resistant tuberculosis in transplant recipients. Transpl Infect Dis. 2023 Aug; 25 (4):e14088 Epub 2023 June 19
    View PubMed
  40. Razonable RR. Neutralizing anti-spike monoclonal antibodies for COVID-19 in vulnerable populations: lessons learned and future directions. Expert Opin Biol Ther. 2023 Jul-Dec; 23 (7):619-631 Epub 2023 June 18
    View PubMed
  41. Inglis SS, Suh GA, Razonable RR, Schettle SD, Spencer PJ, Villavicencio MA, Rosenbaum AN. Infections in Patients With Left Ventricular Assist Devices: Current State and Future Perspectives. ASAIO J. 2023 Jul 1; 69 (7):633-641 Epub 2023 May 04
    View PubMed
  42. Luther VP, Barsoumian AE, Konold VJL, Vijayan T, Balba G, Benson C, Blackburn B, Cariello P, Perloff S, Razonable R, Acharya K, Azar MM, Bhanot N, Blyth D, Butt S, Casanas B, Chow B, Cleveland K, Cutrell JB, Doshi S, Finkel D, Graber CJ, Hazra A, Hochberg NS, James SH, Kaltsas A, Kodiyanplakkal RPL, Lee M, Marcos L, Mena Lora AJ, Moore CC, Nnedu O, Osorio G, Paras ML, Reece R, Salas NM, Sanasi-Bhola K, Schultz S, Serpa JA, Shnekendorf R, Weisenberg S, Wooten D, Zuckerman RA, Melia M, Chirch LM. Inclusion, Diversity, Access, and Equity in Infectious Diseases Fellowship Training: Tools for Program Directors. Open Forum Infect Dis. 2023 Jun; 10 (6):ofad289 Epub 2023 May 27
    View PubMed
  43. Yetmar ZA, Yao JD, Razonable RR. SARS-CoV-2 spike codon mutations and risk of hospitalization after antispike monoclonal antibody therapy in solid organ transplant recipients. J Med Virol. 2023 Jun; 95 (6):e28885
    View PubMed
  44. Ordaya EE, Higgins EM, Vergidis P, Razonable RR, Beam E. Real-world experience of tixagevimab-cilgavimab pre-exposure prophylaxis in orthotopic heart transplant recipients. Transpl Infect Dis. 2023 Jun; 25 (3):e14040 Epub 2023 Feb 27
    View PubMed
  45. Rivera CG, Chesdachai S, Draper EW, Arndt RF, Mara KC, Gonzalez Suarez M, Razonable RR. Clinical outcomes of COVID-19 treated with remdesivir across the continuum of care. Influenza Other Respir Viruses. 2023 May; 17 (5):e13136 Epub 2023 May 17
    View PubMed
  46. Ambrose N, Amin A, Anderson B, Barrera-Oro J, Bertagnolli M, Campion F, Chow D, Danan R, D'Arinzo L, Drews A, Erlandson K, Fitzgerald K, Garcia M, Gaspar FW, Gong C, Hanna G, Jones S, Lopansri B, Musser J, O'Horo J, Piantadosi S, Pritt B, Razonable RR, Roberts S, Sandmeyer S, Stein D, Vahidy F, Webb B, Yttri J. Neutralizing Monoclonal Antibody Use and COVID-19 Infection Outcomes. JAMA Netw Open. 2023 Apr 3; 6 (4):e239694 Epub 2023 Apr 03
    View PubMed
  47. Johnson PW, Kunze KL, Senefeld JW, Sinclair JE, Isha S, Satashia PH, Bhakta S, Cowart JB, Bosch W, O'Horo J, Shah SZ, Wadei HM, Edwards MA, Pollock BD, Edwards AJ, Scheitel-Tulledge S, Clune CG, Hanson SN, Arndt R, Heyliger A, Kudrna C, Bierle DM, Buckmeier JR, Seville MTA, Orenstein R, Libertin C, Ganesh R, Franco PM, Razonable RR, Carter RE, Sanghavi DK, Speicher LL. Association of Neutralizing Antispike Monoclonal Antibody Treatment With Coronavirus Disease 2019 Hospitalization and Assessment of the Monoclonal Antibody Screening Score. Mayo Clin Proc Innov Qual Outcomes. 2023 Apr; 7 (2):109-121 Epub 2023 Jan 11
    View PubMed
  48. Mendoza MA, Ranganath N, Chesdachai S, Yetmar ZA, Razonable R, Abu Saleh O. Immunomodulators for severe coronavirus disease-2019 in transplant patients: Do they increase the risk of secondary infection? Transpl Infect Dis. 2023 Apr; 25 (2):e14050 Epub 2023 Feb 28
    View PubMed
  49. Ordaya EE, Vergidis P, Razonable RR, Yao JD, Beam E. Genotypic and predicted phenotypic analysis of SARS-COV-2 Omicron subvariants in immunocompromised patients with COVID-19 following tixagevimab-cilgavimab prophylaxis. J Clin Virol. 2023 Mar; 160:105382 Epub 2023 Jan 26
    View PubMed
  50. Ranganath N, O'Horo JC, Challener DW, Tulledge-Scheitel SM, Pike ML, O'Brien M, Razonable RR, Shah A. Rebound Phenomenon After Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease 2019 (COVID-19) in High-Risk Persons. Clin Infect Dis. 2023 Feb 8; 76 (3):e537-e539
    View PubMed
  51. Murad MH, Swift MD, Razonable RR, Tande AJ, Wilson JW, Kasten MJ, Sia IG, Matey JN, Vanichkachorn G, Caine NA, Shah V, O'Horo J, Destro Borgen MJ, Cowl CT, Berbari EF. Integrating Infectious Diseases and Preventive Medicine Specialties Into 1 Division: Experience of an Academic Medical Center. Mayo Clin Proc. 2023 Feb; 98 (2):224-228
    View PubMed
  52. Goldman JD, Pouch SM, Woolley AE, Booker SE, Jett CT, Fox C, Berry GJ, Dunn KE, Ho CS, Kittleson M, Lee DH, Levine DJ, Marboe CC, Marklin G, Razonable RR, Taimur S, Te HS, Anesi JA, Fisher CE, Sellers MT, Trindade AJ, Wood RP, Zaffiri L, Levi ME, Klassen D, Michaels MG, La Hoz RM, Danziger-Isakov L. Transplant of organs from donors with positive SARS-CoV-2 nucleic acid testing: A report from the organ procurement and transplantation network ad hoc disease transmission advisory committee. Transpl Infect Dis. 2023 Feb; 25 (1):e14013 Epub 2023 Jan 24
    View PubMed
  53. Ripoll JG, Gorman EK, Juskewitch JE, Razonable RR, Ganesh R, Hurt RT, Theel ES, Stubbs JR, Winters JL, Parikh SA, Kay NE, Joyner MJ, Senefeld JW. Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19. Blood Adv. 2022 Dec 13; 6 (23):5951-5955
    View PubMed
  54. Azar MM, Turbett S, Gaston D, Gitman M, Razonable R, Koo S, Hanson K, Kotton C, Silveira F, Banach DB, Basu SS, Bhaskaran A, Danziger-Isakov L, Bard JD, Gandhi R, Hanisch B, John TM, Odom John AR, Letourneau AR, Luong ML, Maron G, Miller S, Prinzi A, Schwartz I, Simner P, Kumar D, Transplant ID Diagnostics Consensus Conference Working Group. A consensus conference to define the utility of advanced infectious disease diagnostics in solid organ transplant recipients. Am J Transplant. 2022 Dec; 22 (12):3150-3169 Epub 2022 July 27
    View PubMed
  55. Razonable RR, O'Horo JC, Hanson SN, Arndt RF, Speicher LL, Seville TA, Hall ST, Pike ML, Heyliger A, Larsen JJ, Ganesh R, Tulledge-Scheitel SM. Comparable Outcomes for Bebtelovimab and Ritonavir-Boosted Nirmatrelvir Treatment in High-Risk Patients With Coronavirus Disease-2019 During Severe Acute Respiratory Syndrome Coronavirus 2 BA.2 Omicron Epoch. J Infect Dis. 2022 Nov 11; 226 (10):1683-1687
    View PubMed
  56. Yetmar ZA, O'Horo JC, Seville MT, Speicher LL, Ganesh R, Razonable RR. Outcomes of Solid Organ Transplant Recipients Treated With Antispike Monoclonal Antibodies for Coronavirus Disease 2019 Across Variant Epochs: Impact of Comorbidities and Vaccination. Transplantation 2022 Nov 1; 106 (11):e507-e509 Epub 2022 Aug 15
    View PubMed
  57. Abad CLR, Bhaimia E, Schuetz AN, Razonable RR. A comprehensive review of Strongyloides stercoralis infection after solid organ and hematopoietic stem cell transplantation. Clin Transplant. 2022 Nov; 36 (11):e14795 Epub 2022 Sept 20
    View PubMed
  58. Gottlieb RL, Razonable RR. Stewardship of COVID-19 volunteers by nested trial design. Lancet Infect Dis 2022 Oct; 22 (10):1400-1401 Epub 2022 July 05
    View PubMed
  59. Kauke-Navarro M, Panayi AC, Formica R, Marty F, Parikh N, Foroutanjazi S, Safi AF, Mardini S, Razonable RR, Morelon E, Gelb B, Rodriguez E, Lassus P, Pomahac B. Cytomegalovirus-related Complications and Management in Facial Vascularized Composite Allotransplantation: An International Multicenter Retrospective Cohort Study. Transplantation. 2022 Oct 1; 106 (10):2031-2043 Epub 2022 Apr 06
    View PubMed
  60. Razonable RR, Tulledge-Scheitel SM, Hanson SN, Arndt RF, Speicher LL, Seville TA, Larsen JJ, Ganesh R, O'Horo JC. Real-world Clinical Outcomes of Bebtelovimab and Sotrovimab Treatment of High-risk Persons With Coronavirus Disease 2019 During the Omicron Epoch. Open Forum Infect Dis. 2022 Oct; 9 (10):ofac411 Epub 2022 Oct 06
    View PubMed
  61. Sendi P, Razonable RR, Nelson SB, Soriano A, Gandhi RT. First-generation oral antivirals against SARS-CoV-2. Clin Microbiol Infect. 2022 Sep; 28 (9):1230-1235 Epub 2022 May 08
    View PubMed
  62. Razonable RR, O'Horo JC, Challener DW, Arndt L, Arndt RF, Clune CG, Culbertson TL, Hall ST, Heyliger A, Jackson TA, Kennedy BD, Larsen J, Hanson SN, Sweeten PW, Tulledge-Scheitel SM, Ganesh R. Curbing the Delta Surge: Clinical Outcomes After Treatment With Bamlanivimab-Etesevimab, Casirivimab-Imdevimab, or Sotrovimab for Mild to Moderate Coronavirus Disease 2019. Mayo Clin Proc. 2022 Sep; 97 (9):1641-1648 Epub 2022 June 23
    View PubMed
  63. Yetmar ZA, Beam E, O'Horo JC, Seville MT, Brumble L, Ganesh R, Razonable RR. Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild-to-moderate coronavirus disease 2019 during the Omicron epoch. Transpl Infect Dis. 2022 Aug; 24 (4):e13901 Epub 2022 July 25
    View PubMed
  64. Prada LR, Libardo RP, Razonable RR. Immune reconstitution inflammatory syndrome in a non-HIV immunocompromised patient with Pneumocystis Jirovecii pneumonia. Transpl Infect Dis 2022 Aug; 24 (4):e13856 Epub 2022 June 01
    View PubMed
  65. Garson JT, Bernard SA, Deziel PJ, Lemke AI, Rivera CG, Razonable RR. Twice as nice: Cytomegalovirus tele-education. Transpl Infect Dis 2022 Aug; 24 (4):e13865 Epub 2022 June 08
    View PubMed
  66. Yetmar ZA, Bhaimia E, Razonable RR. Antispike monoclonal antibodies for prevention and treatment of coronavirus disease-2019 in solid organ transplant recipients. Curr Opin Organ Transplant. 2022 Aug 1; 27 (4):269-276
    View PubMed
  67. Ordaya EE, Beam E, Yao JD, Razonable RR, Vergidis P. Characterization of Early-Onset Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients Who Received Tixagevimab-Cilgavimab Prophylaxis. Open Forum Infect Dis. 2022 Jul; 9 (7):ofac283 Epub 2022 June 07
    View PubMed
  68. Yetmar ZA, Khodadadi RB, Seville MT, Brumble L, O'Horo JC, Ganesh R, Razonable RR. Outcomes of B-Cell-Depleted Patients With Coronavirus Disease 2019 Treated With Antispike Monoclonal Antibodies. Open Forum Infect Dis. 2022 Jul; 9 (7):ofac204 Epub 2022 Apr 14
    View PubMed
  69. Yetmar ZA, Ranganath N, Mendoza MA, Razonable RR. Clinical and microbiologic outcomes of central nervous system cryptococcosis: Re-examining the need for a 2-week cerebrospinal fluid analysis. Mycoses. 2022 Jul; 65 (7):733-740 Epub 2022 May 25
    View PubMed
  70. Beam E, Destro Borgen MJ, Razonable RR. Infection prevention and control considerations for safe outpatient monoclonal antibody infusions in patients with coronavirus disease 2019 (COVID-19). Infect Control Hosp Epidemiol. 2022 Jun; 43 (6):825-826 Epub 2021 Mar 12
    View PubMed
  71. O'Horo J, Challener DW, Anderson RJ, Arndt RF, Ausman SE, Hall ST, Heyliger A, Kennedy BD, Sweeten PW, Ganesh R, Razonable RR. Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease 2019. Mayo Clin Proc. 2022 May; 97 (5):943-950 Epub 2022 Feb 23
    View PubMed
  72. Thilagar BP, Ghosh AK, Nguyen J, Theiler RN, Wick MJ, Hurt RT, Razonable RR, Ganesh R. Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19). Obstet Gynecol 2022 Apr 1; 139 (4):616-618 Epub 2022 Jan 13
    View PubMed
  73. Yetmar ZA, Bhaimia E, Bierle DM, Ganesh R, Razonable RR. Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy. Transpl Infect Dis. 2022 Apr; 24 (2):e13779 Epub 2022 Jan 31
    View PubMed
  74. Yetmar ZA, Ranganath N, Huebert RC, Rosen CB, Razonable RR, Beam E. Successful Liver Transplantation From a SARS-CoV-2 Positive Donor to a Positive Recipient: Potential Role of Monoclonal Antibodies. Transplantation. 2022 Mar 1; 106 (3):e181-e182
    View PubMed
  75. Bierle DM, Ganesh R, Tulledge-Scheitel S, Hanson SN, Arndt LL, Wilker CG, Razonable RR. Monoclonal Antibody Treatment of Breakthrough COVID-19 in Fully Vaccinated Individuals with High-Risk Comorbidities. J Infect Dis. 2022 Feb 15; 225 (4):598-602
    View PubMed
  76. Singh N, Winston DJ, Razonable RR, Marshall Lyon G, Silveira FP, Wagener MM, Limaye AP. Unexpected Cytomegalovirus (CMV) Replication Kinetics in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients Receiving Preemptive Antiviral Therapy. J Infect Dis. 2022 Feb 1; 225 (3):436-442
    View PubMed
  77. O'Horo JC, Challener DW, Speicher L, Bosch W, Seville MT, Bierle DM, Ganesh R, Wilker CG, Arndt RF, Arndt LL, Tulledge-Scheitel SM, Hanson SN, Razonable RR. Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta Variant. Mayo Clin Proc. 2022 Feb; 97 (2):327-332 Epub 2021 Dec 16
    View PubMed
  78. Ganesh R, Philpot LM, Bierle DM, Razonable RR. Reply to Puing et al. J Infect Dis 2022 Jan 18; 225 (2):353-355
    View PubMed
  79. Razonable RR, Ganesh R, Bierle DM. Clinical Prioritization of Antispike Monoclonal Antibody Treatment of Mild to Moderate COVID-19. Mayo Clin Proc. 2022 Jan; 97 (1):26-30 Epub 2021 Nov 19
    View PubMed
  80. Razonable RR, Ganesh R, Bishop RK, Culbertson TL, Destro Borgen M, Hedin MC, Hopkins LH, Jackson TA, Larsen JJ, Matoush JA, Moehnke DE, Olson SM, Peterson KM, Rosedahl J, Philpot LM. Patient Perspectives on Anti-spike Monoclonal Antibody Therapy for Mild to Moderate Coronavirus Disease-2019. J Patient Exp. 2022; 9:23743735221105673 Epub 2022 June 23
    View PubMed
  81. Klomjit N, El Ters M, Adam BA, Sampathkumar P, Razonable RR, Taler SJ, Taner T, Alexander MP. Diffuse C4d staining of peritubular capillaries in renal allograft following bamlanivimab therapy. Am J Transplant. 2022 Jan; 22 (1):289-293 Epub 2021 Aug 26
    View PubMed
  82. Hiskey L, Madigan T, Ristagno EH, Razonable RR, Ferdjallah A. Prevention and management of human cytomegalovirus in pediatric HSCT recipients: A review. Front Pediatr. 2022; 10:1039938 Epub 2022 Nov 23
    View PubMed
  83. Dhand A, Razonable RR. COVID-19 and Solid Organ Transplantation: Role of Anti-SARS-CoV-2 Monoclonal Antibodies. Curr Transplant Rep. 2022; 9 (1):26-34 Epub 2022 Jan 15
    View PubMed
  84. Razonable RR, O'Horo JC, Hanson SN, Arndt RF, Speicher LL, Seville TA, Hall ST, Pike ML, Heyliger A, Larsen JJ, Ganesh R, Tulledge-Scheitel SM. Comparable outcomes for bebtelovimab and ritonavir-boosted nirmatrelvir treatment in high-risk patients with coronavirus disease-2019 during severe acute respiratory syndrome coronavirus 2 BA.2 Omicron epoch. Journal of Infectious Diseases. 2022; 226 (10):1683-7
  85. Bierle DM, Ganesh R, Razonable RR. Breakthrough COVID-19 and casirivimab-imdevimab treatment during a SARS-CoV-2 B1.617.2 (Delta) surge. J Clin Virol. 2021 Dec; 145:105026 Epub 2021 Nov 08
    View PubMed
  86. Singh N, Winston DJ, Razonable RR, Lyon GM, Silveira FP, Wagener MM, Limaye AP. Cost-effectiveness of Preemptive Therapy Versus Prophylaxis in a Randomized Clinical Trial for the Prevention of Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors. Clin Infect Dis. 2021 Nov 2; 73 (9):e2739-e2745
    View PubMed
  87. Singh N, Winston DJ, Razonable RR, Lyon GM, Huang ML, Jerome KR, Silveira FP, Wagener MM, Limaye AP. Association of HHV-6 With Outcomes in CMV-seronegative Liver Transplant Recipients With CMV-seropositive Donors Receiving Preemptive Antiviral Therapy. Transplantation. 2021 Nov 1; 105 (11):2427-2434
    View PubMed
  88. Ganesh R, Philpot LM, Bierle DM, Anderson RJ, Arndt LL, Arndt RF, Culbertson TL, Destro Borgen MJ, Hanson SN, Kennedy BD, Kottke BB, Larsen JJ, Ramar P, Rosedahl JK, Seville MT, Speicher LL, Tulledge-Scheitel SM, Wilker CG, Razonable RR. Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019. J Infect Dis. 2021 Oct 28; 224 (8):1278-1286
    View PubMed
  89. Chesdachai S, Eberly AR, Razonable RR. A tale of two unusual anaerobic bacterial infections in an immunocompetent man: A case report and literature review. Anaerobe. 2021 Oct; 71:102416 Epub 2021 July 20
    View PubMed
  90. Razonable RR, Pawlowski C, O'Horo JC, Arndt LL, Arndt R, Bierle DM, Borgen MD, Hanson SN, Hedin MC, Lenehan P, Puranik A, Seville MT, Speicher LL, Tulledge-Scheitel SM, Venkatakrishnan AJ, Wilker CG, Badley AD, Ganesh R. Casirivimab-Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19. EClinicalMedicine. 2021 Oct; 40:101102 Epub 2021 Aug 30
    View PubMed
  91. Ganesh R, Pawlowski CF, O'Horo JC, Arndt LL, Arndt RF, Bell SJ, Bierle DM, Borgen MD, Hanson SN, Heyliger A, Larsen JJ, Lenehan PJ, Orenstein R, Puranik A, Speicher LL, Tulledge-Scheitel SM, Venkatakrishnan AJ, Wilker CG, Badley AD, Razonable RR. Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19. J Clin Invest. 2021 Oct 1; 131 (19)
    View PubMed
  92. Rockney D, Benson CA, Blackburn BG, Chirch LM, Konold VJL, Luther VP, Razonable RR, Tackett S, Melia MT. Virtual Recruitment Is Here to Stay: A Survey of ID Fellowship Program Directors and Matched Applicants Regarding Their 2020 Virtual Recruitment Experiences. Open Forum Infect Dis. 2021 Aug; 8 (8):ofab383 Epub 2021 Aug 02
    View PubMed
  93. Kates OS, Stohs EJ, Pergam SA, Rakita RM, Michaels MG, Wolfe CR, Danziger-Isakov L, Ison MG, Blumberg EA, Razonable RR, Gordon EJ, Diekema DS. The limits of refusal: An ethical review of solid organ transplantation and vaccine hesitancy. Am J Transplant. 2021 Aug; 21 (8):2637-2645 Epub 2021 Jan 23
    View PubMed
  94. Yohanathan L, Corsini Campioli C, Campioli CC, Mousa OY, Friedman DZP, Shah V, Ramkissoon R, Hines AS, Kamath PS, Razonable RR, Badley AD, DeMartino ES, Joyner MJ, Graham R, Vergidis P, Simonetto DA, Sanchez W, Taner T, Heimbach JK, Beam E, Leise MD. Liver transplantation for acute liver failure in a SARS-CoV-2 PCR-positive patient. Am J Transplant. 2021 Aug; 21 (8):2890-2894 Epub 2021 May 05
    View PubMed
  95. Bierle DM, Croghan IT, Ganesh R, Wilker CG, Hanson S, Moehnke DE, Jackson TA, Ramar P, Rosedahl JK, Philpot L, Razonable RR. Influence of Social and Cultural Factors on the Decision to Consent for Monoclonal Antibody Treatment among High-Risk Patients with Mild-Moderate COVID-19 Journal of Primary Care and Community Health. 2021.
  96. Singh P, Bentall AJ, Langstraat CL, Swanson AA, Deziel PJ, Huang Y, Razonable RR. A rare manifestation of CMV disease in a kidney transplant recipient. Transpl Infect Dis. 2021 Jun; 23 (3):e13527 Epub 2021 Feb 18
    View PubMed
  97. Yetmar ZA, Beam E, O'Horo JC, Ganesh R, Bierle DM, Brumble L, Seville MT, Razonable RR. Monoclonal Antibody Therapy for COVID-19 in Solid Organ Transplant Recipients. Open Forum Infect Dis. 2021 Jun; 8 (6):ofab255 Epub 2021 June 07
    View PubMed
  98. Corsini Campioli C, Esquer Garrigos Z, Assi M, Go JR, Razonable RR, Beam E, Yao J, Cummins NW. Transient Hepatitis B Surface Antigenemia Following Immunization with Heplisav-B. Mayo Clin Proc Innov Qual Outcomes. 2021 Jun; 5 (3):542-547 Epub 2021 Jan 24
    View PubMed
  99. Kennedy CC, Pennington KM, Beam E, Razonable RR. Fungal Infection in Lung Transplantation. Semin Respir Crit Care Med. 2021 Jun; 42 (3):471-482 Epub 2021 May 24
    View PubMed
  100. Kirisri S, Vongsakulyanon A, Kantachuvesiri S, Razonable RR, Bruminhent J. Predictors of CMV Infection in CMV-Seropositive Kidney Transplant Recipients: Impact of Pretransplant CMV-Specific Humoral Immunity. Open Forum Infect Dis. 2021 Jun; 8 (6):ofab199 Epub 2021 Apr 17
    View PubMed
  101. Razonable RR, Aloia NCE, Anderson RJ, Anil G, Arndt LL, Arndt RF, Ausman SE, Bell SJ, Bierle DM, Billings ML, Bishop RK, Cramer CH, Culbertson TL, Dababneh AS, Derr AN, Epps K, Flaker SM, Ganesh R, Gilmer MA, Urena EG, Gulden CR, Haack TL, Hanson SN, Herzog JR, Heyliger A, Hokanson LD, Hopkins LH, Horecki RJ, Krishna BH, Huskins WC, Jackson TA, Johnson RR, Jorgenson B, Kudrna C, Kennedy BD, Klingsporn MK, Kottke B, Larsen JJ, Lessard SR, Lutwick LI, Malone EJ 3rd, Matoush JA, Micallef IN, Moehnke DE, Mohamed M, Ness CN, Olson SM, Orenstein R, Palraj R, Patel J, Paulson DJ, Phelan D, Peinovich MT, Ramsey WL, Rau-Kane TJ, Reid KI, Reinschmidt KJ, Seville MT, Skold EC, Smith JM, Speicher LL, Spielman LA, Springer DJ, Sweeten PW, Tempelis JM, Tulledge-Scheitel S, Vergidis P, Whipple DC, Wilker CG, Destro Borgen MJ. A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model. Mayo Clin Proc. 2021 May; 96 (5):1250-1261 Epub 2021 Mar 09
    View PubMed
  102. El Helou G, Lahr B, Razonable R. Absolute lymphocyte count as marker of cytomegalovirus and allograft rejection: Is there a "Safe Corridor" after kidney transplantation? Transpl Infect Dis. 2021 Apr; 23 (2):e13489 Epub 2020 Oct 22
    View PubMed
  103. Tulledge-Scheitel S, Bell SJ, Larsen JJ, Bierle DM, Takahashi P, Moehnke DE, Destro Borgen MJ, Springer DJ, Reinschmidt KJ, Baumbach LJ, Matoush JA, Heyliger A, Hanson SN, Razonable RR, Ganesh R. A mobile unit overcomes the challenges to monoclonal antibody infusion for COVID-19 in skilled care facilities. J Am Geriatr Soc. 2021 Apr; 69 (4):868-873 Epub 2021 Mar 05
    View PubMed
  104. Singh N, Winston DJ, Razonable RR, Lyon GM, Silveira FP, Wagener MM, Limaye AP. Risk Factors for Cytomegalovirus Viremia following Liver Transplantation With a Seropositive Donor and Seronegative Recipient Receiving Antiviral Therapy. J Infect Dis. 2021 Mar 29; 223 (6):1073-1077
    View PubMed
  105. O'Horo JC, Cerhan JR, Cahn EJ, Bauer PR, Temesgen Z, Ebbert J, Abril A, Abu Saleh OM, Assi M, Berbari EF, Bierle DM, Bosch W, Burger CD, Cano Cevallos EJ, Clements CM, Carmona Porquera EM, Castillo Almeida NE, Challener DW, Chesdachai S, Comba IY, Corsini Campioli CG, Crane SJ, Dababneh AS, Enzler MJ, Fadel HJ, Ganesh R, De Moraes AG, Go JR, Gordon JE, Gurram PR, Guru PK, Halverson EL, Harrison MF, Heaton HA, Hurt R, Kasten MJ, Lee AS, Levy ER, Libertin CR, Mallea JM, Marshall WF 3rd, Matcha G, Meehan AM, Franco PM, Morice WG 2nd, O'Brien JJ, Oeckler R, Ommen S, Oravec CP, Orenstein R, Ough NJ, Palraj R, Patel BM, Pureza VS, Pickering B, Phelan DM, Razonable RR, Rizza S, Sampathkumar P, Sanghavi DK, Sen A, Siegel JL, Singbartl K, Shah AS, Shweta F, Speicher LL, Suh G, Tabaja H Jr, Tande A, Ting HH, Tontz RC 3rd, Vaillant JJ, Vergidis P, Warsame MY, Yetmar ZA, Zomok CCD, Williams AW, Badley AD. Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research. Mayo Clin Proc. 2021 Mar; 96 (3):601-618 Epub 2020 Dec 26
    View PubMed
  106. Pennington KM, Dykhoff HJ, Yao X, Sangaralingham LR, Shah ND, Peters SG, Barreto JN, Razonable RR, Kennedy CC. The Impact of Antifungal Prophylaxis in Lung Transplant Recipients. Ann Am Thorac Soc. 2021 Mar; 18 (3):468-476
    View PubMed
  107. Chirch LM, Armstrong WS, Balba GP, Kulkarni PA, Benson CA, Konold V, Luther VP, Nnedu ON, Perloff S, Razonable RR, Stead W, Thompson GR 3rd, Melia MT. Education of Infectious Diseases Fellows During the COVID-19 Pandemic Crisis: Challenges and Opportunities. Open Forum Infect Dis. 2021 Feb; 8 (2):ofaa583 Epub 2020 Dec 28
    View PubMed
  108. Berbari HE, Gurram P, Mahmood M, Deziel PJ, Walker RC, Razonable RR. Prosthetic Joint Infections Due to Histoplasma capsulatum: A Report of 3 Cases. Mayo Clin Proc Innov Qual Outcomes. 2021 Feb; 5 (1):225-229 Epub 2021 Jan 21
    View PubMed
  109. Singh P, Razonable RR, Lorenz EC, DiCaudo DJ, Sukov WR, Bridges AG, Alkhateeb HB, Hogan WJ, Klomjit N, Thirunavukkarasu S, Amer H, Kudva YC, Khamash H, Stegall M, Kukla A. Chronic graft-versus-host disease in pancreas after kidney transplant recipients - An unrecognized entity. Am J Transplant. 2021 Feb; 21 (2):883-888 Epub 2020 Sept 20
    View PubMed
  110. Bierle DM, Ganesh R, Wilker CG, Hanson SN, Moehnke DE, Jackson TA, Ramar P, Rosedahl JK, Philpot LM, Razonable RR. Influence of Social and Cultural Factors on the Decision to Consent for Monoclonal Antibody Treatment among High-Risk Patients with Mild-Moderate COVID-19. J Prim Care Community Health. 2021 Jan-Dec; 12:21501327211019282
    View PubMed
  111. Cano EJ, Yetmar ZA, Razonable RR. Cryptococcus Species Other Than Cryptococcus neoformans and Cryptococcus gattii: Are They Clinically Significant? Open Forum Infect Dis. 2020 Dec; 7 (12):ofaa527 Epub 2020 Oct 29
    View PubMed
  112. Temesgen Z, Assi M, Shweta FNU, Vergidis P, Rizza SA, Bauer PR, Pickering BW, Razonable RR, Libertin CR, Burger CD, Orenstein R, Vargas HE, Palraj R, Dababneh AS, Chappell G, Chappell D, Ahmed O, Sakemura R, Durrant C, Kenderian SS, Badley AD. GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study. Mayo Clin Proc. 2020 Nov; 95 (11):2382-2394 Epub 2020 Sept 03
    View PubMed
  113. Razonable RR, Carmona EM, Vergidis P, Wilson JW, Marshall WF 3rd. Clinical Guidance and the Delivery of Care for Patients With Coronavirus Disease 2019. Mayo Clin Proc. 2020 Sep; 95 (9S):S23-S25 Epub 2020 June 23
    View PubMed
  114. Razonable RR, Marshall WF 3rd, Stevens RW, Kumar S, Murad MH, Wilson WR. Rapid Appraisal System for COVID-19 Medical Information. Mayo Clin Proc. 2020 Sep; 95 (9S):S26-S28 Epub 2020 June 22
    View PubMed
  115. Suh GA, Shah AS, Kasten MJ, Virk A, Domonoske CL, Razonable RR. Avoiding a Medical Education Quarantine During the Pandemic. Mayo Clin Proc. 2020 Sep; 95 (9S):S63-S65 Epub 2020 June 20
    View PubMed
  116. Pennington KM, Baqir M, Erwin PJ, Razonable RR, Murad MH, Kennedy CC. Antifungal prophylaxis in lung transplant recipients: A systematic review and meta-analysis. Transpl Infect Dis. 2020 Aug; 22 (4):e13333 Epub 2020 June 16
    View PubMed
  117. Wagner T, Shweta F, Murugadoss K, Awasthi S, Venkatakrishnan AJ, Bade S, Puranik A, Kang M, Pickering BW, O'Horo JC, Bauer PR, Razonable RR, Vergidis P, Temesgen Z, Rizza S, Mahmood M, Wilson WR, Challener D, Anand P, Liebers M, Doctor Z, Silvert E, Solomon H, Anand A, Barve R, Gores G, Williams AW, Morice WG 2nd, Halamka J, Badley A, Soundararajan V. Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis. Elife. 2020 Jul 7; 9 Epub 2020 July 07
    View PubMed
  118. Vijayvargiya P, Esquer Garrigos Z, Castillo Almeida NE, Gurram PR, Stevens RW, Razonable RR. Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof). Mayo Clin Proc. 2020 Jul; 95 (7):1454-1466 Epub 2020 Apr 30
    View PubMed
  119. Razonable RR, Pennington KM, Meehan AM, Wilson JW, Froemming AT, Bennett CE, Marshall AL, Virk A, Carmona EM. A Collaborative Multidisciplinary Approach to the Management of Coronavirus Disease 2019 in the Hospital Setting. Mayo Clin Proc. 2020 Jul; 95 (7):1467-1481 Epub 2020 May 30
    View PubMed
  120. Razonable RR, Marshall WF, Stevens RW, Kumar S, Murad MH, Wilson WR. Mayo Clinic strategies for COVID-19 rapid appraisal system for COVID-19 medical information Mayo Clinic Proceeding. 2020.
  121. Temesgen Z, Assi M, Vergidis P, Rizza SA, Bauer PR, Pickering BW, Razonable RR, Libertin CR, Burger CD, Orenstein R, Vargas HE, Varatharaj Palraj BR, Dababneh AS, Chappell G, Chappell D, Ahmed O, Sakemura R, Durrant C, Kenderian SS, Badley A. First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe COVID-19 Pneumonia. medRxiv 2020 Jun 14 Epub 2020 June 14
    View PubMed
  122. El Helou G, Razonable R. Next-generatino Sequencing to Assess Cytomegalovirus Viral Populations During the Course of CMV Infection American Transplant Congress, Philadelphia, PA. 2020.
  123. Singh N, Winston DJ, Razonable RR, Lyon GM, Silveira FP, Wagener MM, Stevens-Ayers T, Edmison B, Boeckh M, Limaye AP. Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical Trial. JAMA. 2020 Apr 14; 323 (14):1378-1387
    View PubMed
  124. Vijayvargiya P, Garrigos ZE, Rodino KG, Razonable RR, Abu Saleh OM. Clostridium paraputrificum septic arthritis and osteomyelitis of shoulder: A case report and review of literature. Anaerobe. 2020 Apr; 62:102105 Epub 2019 Oct 01
    View PubMed
  125. Razonable RR, Inoue N, Pinninti SG, Boppana SB, Lazzarotto T, Gabrielli L, Simonazzi G, Pellett PE, Schmid DS. Clinical Diagnostic Testing for Human Cytomegalovirus Infections. J Infect Dis. 2020 Mar 5; 221 (Suppl 1):S74-S85
    View PubMed
  126. Melia MT, Paez A, Reid G, Chirch LM, Luther VP, Blackburn BG, Perez F, Abdoler E, Kaul DR, Rehm S, Harik N, Barsoumian A, Person AK, Yun H, Beckham JD, Boruchoff S, Cariello PF, Cutrell JB, Graber CJ, Lee DH, Maziarz E, Paras ML, Razonable RR, Ressner R, Chen A, Chow B, Escota G, Herc E, Johnson A, Maves RC, Nnedu O, Clauss H, Kulkarni P, Pottinger PS, Serpa JA, Bhowmick T, Bittner M, Wooten D, Casanas B, Shnekendorf R, Blumberg EA. The Struggling Infectious Diseases Fellow: Remediation Challenges and Opportunities. Open Forum Infect Dis. 2020 Mar; 7 (3):ofaa058 Epub 2020 Feb 18
    View PubMed
  127. Meesing A, Germer JJ, Yao JD, Gartner ML, Digmann BJ, Razonable RR. Differences in Duration and Degree of Cytomegalovirus DNAemia Observed With Two Standardized Quantitative Nucleic Acid Tests and Implications for Clinical Care. J Infect Dis. 2020 Jan 2; 221 (2):251-255
    View PubMed
  128. Razonable RR. Cytomegalovirus in Solid Organ Transplant Recipients: Clinical Updates, Challenges and Future Directions. Curr Pharm Des. 2020; 26 (28):3497-3506
    View PubMed
  129. Abad CL, Razonable RR. Prevention and treatment of tuberculosis in solid organ transplant recipients. Expert Rev Anti Infect Ther. 2020 Jan; 18 (1):63-73 Epub 2019 Dec 18
    View PubMed
  130. Abad CLR, Deziel PJ, Razonable RR. Treatment of latent TB Infection and the risk of tuberculosis after solid organ transplantation: Comprehensive review. Transpl Infect Dis. 2019 Dec; 21 (6):e13178 Epub 2019 Oct 01
    View PubMed
  131. El Helou G, Razonable RR. Safety considerations with current and emerging antiviral therapies for cytomegalovirus infection in transplantation. Expert Opin Drug Saf. 2019 Nov; 18 (11):1017-1030 Epub 2019 Sept 06
    View PubMed
  132. Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019 Sep; 33 (9):e13512 Epub 2019 Mar 28
    View PubMed
  133. Valencia JCB, Abdel MP, Virk A, Osmon DR, Razonable RR. Destination Joint Spacers, Reinfection, and Antimicrobial Suppression. Clin Infect Dis. 2019 Aug 30; 69 (6):1056-1059
    View PubMed
  134. Pennington KM, Yost KJ, Escalante P, Razonable RR, Kennedy CC. Antifungal prophylaxis in lung transplant: A survey of United States' transplant centers. Clin Transplant. 2019 Jul; 33 (7):e13630 Epub 2019 June 23
    View PubMed
  135. Fida M, Hamdi AM, Bryson A, Razonable RR, Abu Saleh O. Long-term Outcomes of Patients With Human Herpesvirus 6 Encephalitis. Open Forum Infect Dis. 2019 Jul; 6 (7):ofz269 Epub 2019 June 05
    View PubMed
  136. Anderson NW, Muehlenbachs A, Arif S, Bruminhent J, Deziel PJ, Razonable RR, Wilhelm MP, Metcalfe MG, Qvarnstrom Y, Pritt BS. A Fatal Case of Disseminated Microsporidiosis Due to Anncaliia algerae in a Renal and Pancreas Allograft Recipient. Open Forum Infect Dis. 2019 Jul; 6 (7):ofz285 Epub 2019 July 08
    View PubMed
  137. Pennington KM, Razonable RR, Peters S, Scott JP, Wylam M, Daly RC, Kennedy CC. Why do lung transplant patients discontinue triazole prophylaxis? Transpl Infect Dis. 2019 Jun; 21 (3):e13067 Epub 2019 Mar 27
    View PubMed
  138. Chemaly RF, Chou S, Einsele H, Griffiths P, Avery R, Razonable RR, Mullane KM, Kotton C, Lundgren J, Komatsu TE, Lischka P, Josephson F, Douglas CM, Umeh O, Miller V, Ljungman P, Resistant Definitions Working Group of the Cytomegalovirus Drug Development Forum. Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials. Clin Infect Dis. 2019 Apr 8; 68 (8):1420-1426
    View PubMed
  139. Meesing A, Abraham RS, Razonable RR. Clinical Correlation of Cytomegalovirus Infection With CMV-specific CD8+ T-cell Immune Competence Score and Lymphocyte Subsets in Solid Organ Transplant Recipients. Transplantation. 2019 Apr; 103 (4):832-838
    View PubMed
  140. Ritchie BM, Barreto JN, Barreto EF, Crow SA, Dierkhising RA, Jannetto PJ, Tosh PK, Razonable RR. Relationship of Ganciclovir Therapeutic Drug Monitoring with Clinical Efficacy and Patient Safety. Antimicrob Agents Chemother. 2019 Mar; 63 (3) Epub 2019 Feb 26
    View PubMed
  141. Razonable RR, Amer H, Mardini S. Application of a New Paradigm for Cytomegalovirus Disease Prevention in Mayo Clinic's First Face Transplant. Mayo Clin Proc. 2019 Jan; 94 (1):166-170
    View PubMed
  142. Beam E, Razonable RR. A survey of infection prevention and control practices among solid organ transplantation centers. Am J Infect Control. 2019 Jan; 47 (1):101-104 Epub 2018 Oct 05
    View PubMed
  143. El Helou G, Razonable RR. Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review. Infect Drug Resist. 2019; 12:1481-1491 Epub 2019 June 04
    View PubMed
  144. Abad CLR, Razonable RR. An update on Mycobacterium tuberculosis infection after hematopoietic stem cell transplantation in adults. Clin Transplant. 2018 Dec; 32 (12):e13430 Epub 2018 Nov 11
    View PubMed
  145. Laub MR, Crow SA, Personett HA, Dierkhising R, Boilson B, Razonable R. Effects of clotrimazole troches on tacrolimus dosing in heart transplant recipients. Transpl Infect Dis. 2018 Dec; 20 (6):e12979 Epub 2018 Sept 03
    View PubMed
  146. Meesing A, Razonable RR. Absolute Lymphocyte Count Thresholds: A Simple, Readily Available Tool to Predict the Risk of Cytomegalovirus Infection After Transplantation. Open Forum Infect Dis. 2018 Oct; 5 (10):ofy230 Epub 2018 Sept 11
    View PubMed
  147. Abad CLR, Razonable RR. Donor derived Mycobacterium tuberculosis infection after solid-organ transplantation: A comprehensive review. Transpl Infect Dis. 2018 Oct; 20 (5):e12971 Epub 2018 Aug 12
    View PubMed
  148. Meesing A, Razonable RR. Pharmacologic and immunologic management of cytomegalovirus infection after solid organ and hematopoietic stem cell transplantation. Expert Rev Clin Pharmacol. 2018 Aug; 11 (8):773-788 Epub 2018 July 26
    View PubMed
  149. Razonable RR. Role of letermovir for prevention of cytomegalovirus infection after allogeneic haematopoietic stem cell transplantation. Curr Opin Infect Dis. 2018 Aug; 31 (4):286-291
    View PubMed
  150. Razonable RR. Drug-resistant cytomegalovirus: clinical implications of specific mutations. Curr Opin Organ Transplant. 2018 Aug; 23 (4):388-394
    View PubMed
  151. Meesing A, Razonable RR. New Developments in the Management of Cytomegalovirus Infection After Transplantation. Drugs. 2018 Jul; 78 (11):1085-1103
    View PubMed
  152. Abad CLR, Razonable RR. Mycobacterium tuberculosis after solid organ transplantation: A review of more than 2000 cases. Clin Transplant. 2018 Jun; 32 (6):e13259 Epub 2018 May 07
    View PubMed
  153. Deziel PJ, Razonable R. Anti-infective chemoprophylaxis after solid-organ transplantation. Expert Rev Clin Immunol. 2018 Jun; 14 (6):469-479 Epub 2018 June 06
    View PubMed
  154. Phan TL, Lautenschlager I, Razonable RR, Munoz FM. HHV-6 in liver transplantation: A literature review. Liver Int. 2018 Feb; 38 (2):210-223 Epub 2017 July 29
    View PubMed
  155. Wieruszewski PM, Vijayvargiya P, Wilhelm MP, Razonable RR. Cytomegaloviraemia clearance with foscarnet during renal replacement therapy. J Antimicrob Chemother. 2018 Feb 1; 73 (2):548-549
    View PubMed
  156. Beeching NJ, Carratala J, Razonable RR, Oriol I, Vilela EG. Traveler's Diarrhea Recommendations for Solid Organ Transplant Recipients and Donors. Transplantation. 2018 Feb; 102 (2S Suppl 2):S35-S41
    View PubMed
  157. Beam E, Germer JJ, Lahr B, Yao JD, Limper AH, Binnicker MJ, Razonable RR. Cytomegalovirus (CMV) DNA quantification in bronchoalveolar lavage fluid of immunocompromised patients with CMV pneumonia. Clin Transplant. 2018 Jan; 32 (1) Epub 2017 Dec 08
    View PubMed
  158. Tariq R, Pardi DS, Tosh PK, Walker RC, Razonable RR, Khanna S. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency. Clin Infect Dis. 2017 Oct 30; 65(10):1745-1747.
    View PubMed
  159. Kennedy CC, Razonable RR. Fungal Infections After Lung Transplantation. Clin Chest Med. 2017 Sep; 38 (3):511-520 Epub 2017 May 20
    View PubMed
  160. Razonable RR. Progress Toward HHV-8 Prevention After Transplantation: In Search for Optimal Diagnostic Strategies. Transplantation 2017 Aug; 101 (8):1751-1752
    View PubMed
  161. Ramanan P, Cummins NW, Wilhelm MP, Heimbach JK, Dierkhising R, Kremers WK, Rosen CB, Gores GJ, Razonable RR. Epidemiology, risk factors, and outcomes of infections in patients undergoing liver transplantation for hilar cholangiocarcinoma. Clin Transplant. 2017 Aug; 31 (8) Epub 2017 July 05
    View PubMed
  162. Ramanan P, Razonable RR. Evaluation of COBAS AmpliPrep/COBAS TaqMan CMV Test for use in hematopoietic stem cell transplant recipients. Expert Rev Mol Diagn. 2017 Jul; 17 (7):633-639 Epub 2017 May 15
    View PubMed
  163. Dioverti MV, Lahr BD, Germer JJ, Yao JD, Gartner ML, Razonable RR. Comparison of Standardized Cytomegalovirus (CMV) Viral Load Thresholds in Whole Blood and Plasma of Solid Organ and Hematopoietic Stem Cell Transplant Recipients with CMV Infection and Disease. Open Forum Infect Dis. 2017 Summer; 4 (3):ofx143 Epub 2017 July 08
    View PubMed
  164. Bruminhent J, Cawcutt KA, Thongprayoon C, Petterson TM, Kremers WK, Razonable RR. Epidemiology, risk factors, and outcome of Clostridium difficile infection in heart and heart-lung transplant recipients. Clin Transplant. 2017 Jun; 31 (6) Epub 2017 Apr 17
    View PubMed
  165. Singh N, Sifri CD, Silveira FP, Miller R, Gregg KS, Huprikar S, Lease ED, Zimmer A, Dummer JS, Spak CW, Koval C, Banach DB, Shroff M, Le J, Ostrander D, Avery R, Eid A, Razonable RR, Montero J, Blumberg E, Alynbiawi A, Morris MI, Randall HB, Alangaden G, Tessier J, Cacciarelli TV, Wagener MM, Sun HY. Unique characteristics of cryptococcosis identified after death in patients with liver cirrhosis: comparison with concurrent cohort diagnosed antemortem. Med Mycol. 2017 Apr 1; 55 (3):278-284
    View PubMed
  166. Abad CL, Lahr BD, Razonable RR. Epidemiology and risk factors for infection after living donor liver transplantation. Liver Transpl. 2017 Apr; 23 (4):465-477
    View PubMed
  167. Vergidis P, Ariza-Heredia EJ, Nellore A, Kotton CN, Kaul DR, Morris MI, Kelesidis T, Shah H, Park SY, Nguyen MH, Razonable RR. Rhodococcus Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients1. Emerg Infect Dis. 2017 Mar; 23: (3)510-512.
    View PubMed
  168. Abad CL, Razonable RR. Treatment of alpha and beta herpesvirus infections in solid organ transplant recipients. Expert Rev Anti Infect Ther. 2017 Feb; 15 (2):93-110 Epub 2016 Dec 12
    View PubMed
  169. Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G, Pikis A, Razonable RR, Miller V, Griffiths PD, Disease Definitions Working Group of the Cytomegalovirus Drug Development Forum. Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials. Clin Infect Dis. 2017 Jan 1; 64 (1):87-91 Epub 2016 Sept 28
    View PubMed
  170. Aburjania N, Abu Saleh OM, Razonable RR. How do we treat human herpesvirus 6 infection after allogeneic hematopoietic stem cell transplantation? Future Virology. 2017; 12(3):85-8. Epub 1900 Jan 01.
  171. Hefazi M, Damlaj M, Alkhateeb HB, Partain DK, Patel R, Razonable RR, Gastineau DA, Al-Kali A, Hashmi SK, Hogan WJ, Litzow MR, Patnaik MM. Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia. Transpl Infect Dis. 2016 Dec; 18 (6):913-920 Epub 2016 Nov 11
    View PubMed
  172. Tyner HL, Virk A, Nassr A, Razonable R. Mycoplasma hominis vertebral spine infection: Case report and a review of infections of bone and joints. J Infect Chemother. 2016 Nov; 22 (11):755-758 Epub 2016 May 24
    View PubMed
  173. Abad CL, Razonable RR. alpha Herpes Virus Infections Among Renal Transplant Recipients. Semin Nephrol. 2016 Sep; 36 (5):344-350
    View PubMed
  174. Razonable RR. Not the Usual Viral Suspects: Parvovirus B19, West Nile Virus, and Human T-Cell Lymphotrophic Virus Infections After Kidney Transplantation. Semin Nephrol. 2016 Sep; 36 (5):428-434
    View PubMed
  175. Dioverti MV, Razonable RR. Cytomegalovirus. Microbiol Spectr. 2016 Aug; 4 (4)
    View PubMed
  176. Abad CL, Razonable RR. Non-tuberculous mycobacterial infections in solid organ transplant recipients: An update. J Clin Tuberc Other Mycobact Dis. 2016 Aug; 4:1-8 Epub 2016 Apr 27
    View PubMed
  177. Pinto GG, Poloni JA, Rotta LN, Razonable RR, Pasqualotto AC. Screening for BK virus nephropathy in kidney transplant recipients: comparison of diagnostic tests. J Bras Nefrol. 2016 Jul-Sep; 38 (3):356-362
    View PubMed
  178. Beaird OE, Freifeld A, Ison MG, Lawrence SJ, Theodoropoulos N, Clark NM, Razonable RR, Alangaden G, Miller R, Smith J, Young JA, Hawkinson D, Pursell K, Kaul DR. Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative. Transpl Infect Dis. 2016 Apr; 18 (2):210-5 Epub 2016 Mar 29
    View PubMed
  179. Beam E, Keating MR, Razonable RR. A Survey of Infection Prevention and Control Practices among Hematopoietic Stem Cell Transplant Centers. Infect Control Hosp Epidemiol. 2016 Mar; 37: (3)348-51.
    View PubMed
  180. Beam E, Lesnick T, Kremers W, Kennedy CC, Razonable RR. Cytomegalovirus disease is associated with higher all-cause mortality after lung transplantation despite extended antiviral prophylaxis. Clin Transplant. 2016 Mar; 30 (3):270-8 Epub 2016 Mar 01
    View PubMed
  181. Dioverti MV, Lahr B, Razonable RR. Treatment of cytomegalovirus infection and disease pre- and post-quantitative nucleic acid test standardization: does use of a more sensitive assay lead to longer treatment duration? Clin Transplant. 2016 Feb; 30: (2)154-60.
    View PubMed
  182. Dioverti MV, Razonable RR. Cytomegalovirus Microbiology Spectrum. 2016; 4: (4)DMIH2-0022-2015.
  183. Singh N, Sifri CD, Silveira FP, Miller R, Gregg KS, Huprikar S, Lease ED, Zimmer A, Dummer JS, Spak CW, Koval C, Banach DB, Shroff M, Le J, Ostrander D, Avery R, Eid A, Razonable RR, Montero J, Blumberg E, Alynbiawi A, Morris MI, Randall HB, Alangaden G, Tessier J, Wagener MM, Sun HY. Cryptococcosis in Patients With Cirrhosis of the Liver and Posttransplant Outcomes. Transplantation. 2015 Oct; 99 (10):2132-41
    View PubMed
  184. Dioverti MV, Razonable RR. Clinical utility of cytomegalovirus viral load in solid organ transplant recipients. Curr Opin Infect Dis. 2015 Aug; 28 (4):317-22
    View PubMed
  185. Bruminhent J, Thongprayoon C, Dierkhising RA, Kremers WK, Theel ES, Razonable RR. Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome? Liver Transpl. 2015 Apr; 21: (4)539-46.
    View PubMed
  186. Chong PP, Kennedy CC, Hathcock MA, Kremers WK, Razonable RR. Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis. Clin Transplant. 2015 Apr; 29(4):311-8. Epub 2015 Feb 12.
    View PubMed
  187. Sun HY, Alexander BD, Huprikar S, Forrest GN, Bruno D, Lyon GM, Wray D, Johnson LB, Sifri CD, Razonable RR, Morris MI, Stosor V, Wagener MM, Singh N. Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression. Clin Infect Dis. 2015 Jan 1; 60 (1):36-44 Epub 2014 Sept 09
    View PubMed
  188. Melendez DP, Razonable RR. Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus. Infect Drug Resist. 2015; 8:269-77 Epub 2015 Aug 05
    View PubMed
  189. Bruminhent J, Deziel PJ, Wotton JT, Binnicker MJ, Razonable RR. Prolonged shedding of pandemic influenza A (H1N1) 2009 virus in a pancreas-after-kidney transplant recipient. J Clin Virol. 2014 Oct; 61(2):302-4. Epub 2014 Jul 16.
    View PubMed
  190. Ramanan P, Deziel PJ, Norby SM, Yao JD, Garza I, Razonable RR. Donor-transmitted HTLV-1-associated myelopathy in a kidney transplant recipient--case report and literature review. Am J Transplant. 2014 Oct; 14 (10):2417-21 Epub 2014 Aug 19
    View PubMed
  191. Melendez D, Razonable RR. Immune-based monitoring for cytomegalovirus infection in solid organ transplantation: is it ready for clinical primetime? Expert Rev Clin Immunol. 2014 Sep; 10(9):1213-27. Epub 2014 Jul 31.
    View PubMed
  192. Beam E, Dioverti V, Razonable RR. Emerging cytomegalovirus management strategies after solid organ transplantation: challenges and opportunities. Curr Infect Dis Rep. 2014 Sep; 16 (9):419
    View PubMed
  193. Bruminhent J, Razonable RR. Outcomes of patients with cytomegalovirus viremia at the time of liver transplantation. Liver Transpl. 2014 Sep; 20(9):1029-33. Epub 2014 Aug 04.
    View PubMed
  194. Marcelin JR, Beam E, Razonable RR. Cytomegalovirus infection in liver transplant recipients: updates on clinical management. World J Gastroenterol. 2014 Aug 21; 20 (31):10658-67
    View PubMed
  195. Khare R, Gupta S, Arif S, Jentoft ME, Deziel PJ, Roden AC, Wilhelm MP, Razonable RR, Wengenack NL. Misidentification of Neosartorya pseudofischeri as Aspergillus fumigatus in a lung transplant patient. J Clin Microbiol. 2014 Jul; 52 (7):2722-5 Epub 2014 May 14
    View PubMed
  196. Bruminhent J, Razonable RR. Management of cytomegalovirus infection and disease in liver transplant recipients. World J Hepatol. 2014 Jun 27; 6 (6):370-83
    View PubMed
  197. Ramanan P, Deziel PJ, Razonable RR. Rhodococcus globerulus bacteremia in an allogeneic hematopoietic stem cell transplant recipient: report of the first transplant case and review of the literature. Transpl Infect Dis. 2014 Jun; 16(3):484-9. Epub 2014 May 02.
    View PubMed
  198. Ariza-Heredia EJ, Beam EN, Lesnick TG, Cosio FG, Kremers WK, Razonable RR. Impact of urinary tract infection on allograft function after kidney transplantation. Clin Transplant. 2014 Jun; 28 (6):683-90 Epub 2014 Apr 27
    View PubMed
  199. Vergidis P, Razonable RR, Wheat LJ, Estes L, Caliendo AM, Baden LR, Wingard JR, Baddley J, Assi M, Norris S, Chandrasekar P, Shields R, Nguyen H, Freifeld A, Kohler R, Kleiman M, Walsh TJ, Hage CA. Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States. J Clin Microbiol. 2014 Jun; 52 (6):2199-201 Epub 2014 Apr 09
    View PubMed
  200. Marcelin JR, Wilson JW, Razonable RR, Mayo Clinic Hematology/Oncology and Transplant Infectious Diseases Services. Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients. Transpl Infect Dis. 2014 Apr; 16: (2)242-50.
    View PubMed
  201. Bruminhent J, Razonable RR. Management of Cytomegalovirus Infection and Disease in Liver Transplant Recipients. World Journal of Hepatology.2014;6:(6):370-83.
  202. Dave M, Purohit T, Razonable R, Loftus EV Jr. Opportunistic infections due to inflammatory bowel disease therapy. Inflamm Bowel Dis. 2014 Jan; 20 (1):196-212
    View PubMed
  203. Ramanan P, Razonable RR. Elizabethkingia species sepsis after lung transplantation: case report and literature review. Transpl Infect Dis. 2013 Dec; 15(6):E229-34. Epub 2013 Oct 14.
    View PubMed
  204. Razonable RR, Hayden RT. Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation. Clin Microbiol Rev. 2013 Oct; 26 (4):703-27
    View PubMed
  205. Reid G, Huprikar S, Patel G, Razonable RR, Mossad S, Levi M, Gregg K, Shoham S, Humar A, Adams W, Kumar D. A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2013 Oct; 15(5):487-92. Epub 2013 Jul 25.
    View PubMed
  206. Ramanan P, Razonable RR. Cytomegalovirus infections in solid organ transplantation: a review. Infect Chemother. 2013 Sep; 45 (3):260-71 Epub 2013 Sept 27
    View PubMed
  207. Chong PP, Razonable RR. Diagnostic and management strategies for donor-derived infections. Infect Dis Clin North Am. 2013 Jun; 27(2):253-70. Epub 2013 Mar 26.
    View PubMed
  208. Razonable RR. Management strategies for cytomegalovirus infection and disease in solid organ transplant recipients. Infect Dis Clin North Am. 2013 Jun; 27 (2):317-42 Epub 2013 Mar 26
    View PubMed
  209. Razonable RR, Asberg A, Rollag H, Duncan J, Boisvert D, Yao JD, Caliendo AM, Humar A, Do TD. Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients. Clin Infect Dis. 2013 Jun; 56 (11):1546-53 Epub 2013 Feb 15
    View PubMed
  210. Ariza-Heredia EJ, Beam EN, Lesnick TG, Kremers WK, Cosio FG, Razonable RR. Urinary tract infections in kidney transplant recipients: role of gender, urologic abnormalities, and antimicrobial prophylaxis. Ann Transplant. 2013 May 6; 18:195-204 Epub 2013 May 06
    View PubMed
  211. Lee SO, Brown RA, Razonable RR. Association between a functional polymorphism in Toll-like receptor 3 and chronic hepatitis C in liver transplant recipients. Transpl Infect Dis. 2013 Apr; 15(2):111-9. Epub 2012 Dec 13.
    View PubMed
  212. Razonable RR, Humar A, AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ transplantation. Am J Transplant. 2013 Mar; 13 Suppl 4:93-106
    View PubMed
  213. Razonable RR. Human herpesviruses 6, 7 and 8 in solid organ transplant recipients. Am J Transplant. 2013 Feb; 13 Suppl 3:67-77; quiz 77-8
    View PubMed
  214. Beam E, Razonable RR. Cytomegalovirus in solid organ transplantation: epidemiology, prevention, and treatment. Curr Infect Dis Rep. 2012 Dec; 14 (6):633-41
    View PubMed
  215. Lee SO, Brown RA, Razonable RR. Chromosomally integrated human herpesvirus-6 in transplant recipients. Transpl Infect Dis. 2012 Aug; 14(4):346-54. Epub 2012 Feb 09.
    View PubMed
  216. Vergidis P, Lesnick TG, Kremers WK, Razonable RR. Prosthetic joint infection in solid organ transplant recipients: a retrospective case-control study. Transpl Infect Dis. 2012 Aug; 14 (4):380-6 Epub 2012 Jan 20
    View PubMed
  217. Ariza-Heredia EJ, Patel R, Blumberg EA, Walker RC, Lewis R, Evans J, Sankar A, Willliams MD, Rogers J, Milano C, Razonable RR. Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. Transpl Infect Dis. 2012 Jun; 14(3):229-36. Epub 2012 May 25.
    View PubMed
  218. Watkins RR, Lemonovich TL, Razonable RR. Immune response to CMV in solid organ transplant recipients: current concepts and future directions. Expert Rev Clin Immunol. 2012 May; 8(4):383-93.
    View PubMed
  219. Pellett PE, Ablashi DV, Ambros PF, Agut H, Caserta MT, Descamps V, Flamand L, Gautheret-Dejean A, Hall CB, Kamble RT, Kuehl U, Lassner D, Lautenschlager I, Loomis KS, Luppi M, Lusso P, Medveczky PG, Montoya JG, Mori Y, Ogata M, Pritchett JC, Rogez S, Seto E, Ward KN, Yoshikawa T, Razonable RR. Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol. 2012 May; 22 (3):144-55 Epub 2011 Nov 04
    View PubMed
  220. Lautenschlager I, Razonable RR. Human herpesvirus-6 infections in kidney, liver, lung, and heart transplantation: review. Transpl Int. 2012 May; 25(5):493-502. Epub 2012 Feb 23.
    View PubMed
  221. Tapia GG, Razonable RR, Eckel-Passow JE, Lahr BD, Afessa B, Keegan MT, Catania J, Baddour LM. A scoring model of factors associated with Candida glabrata candidemia among critically ill patients. Mycoses. 2012 May; 55(3):228-36. Epub 2011 Jul 21.
    View PubMed
  222. Grossi PA, Costa AN, Fehily D, Blumberg EA, Kuehnert MJ, Fishman JA, Ison MG, Lattes R, Kotton CN, Lilleri D, Kabanova A, Lanzavecchia A, Gerna G, Razonable RR, Comoli P, Zecca M, Basso S, Ginevri F, Grossi A, Schena FP, Rimola A, Burra P, De Martin E, Rodriguez-Castro KI, Fagiuoli S, Pasulo L, Bruno R, Andreone P, Loggi E, Arena F, Maria Rossolini G, Sganga G, Cozza V. Infections and organ transplantation: new challenges for prevention and treatment--a colloquium. Transplantation. 2012 Mar 15; 93(5 Suppl):S4-S39.
    View PubMed
  223. Kang SH, Abdel-Massih RC, Brown RA, Dierkhising RA, Kremers WK, Razonable RR. Homozygosity for the toll-like receptor 2 R753Q single-nucleotide polymorphism is a risk factor for cytomegalovirus disease after liver transplantation. J Infect Dis. 2012 Feb 15; 205 (4):639-46 Epub 2012 Jan 04
    View PubMed
  224. Ariza-Heredia EJ, Fishman JE, Cleary T, Smith L, Razonable RR, Abbo L. Clinical and radiological features of respiratory syncytial virus in solid organ transplant recipients: a single-center experience. Transpl Infect Dis. 2012 Feb; 14: (1)64-71.
    View PubMed
  225. Ariza-Heredia E, Razonable RR. Incidental hepatic schistosomiasis in a liver transplant recipient. Transpl Infect Dis. 2012 Feb; 14(1):75-8. Epub 2011 Apr 19.
    View PubMed
  226. Winston DJ Saliba F Blumberg E Abouljoud M Garcia-Diaz JB Goss JA Clough L Avery R Limaye AP Ericzon BG Navasa M Troisi RI Chen H Villano SA Uknis ME, 1263-301 Clinical Study Group (including Razonable RR). Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double-blind, multicenter controlled trial. Amerian Journal of Transplantation. 2012; 12(11):3021-30.
  227. Razonable RR. Rare, unusual, and less common virus infections after organ transplantation. Curr Opin Organ Transplant. 2011 Dec; 16(6):580-7.
    View PubMed
  228. Ariza-Heredia EJ, Dababneh AS, Wilhelm MP, Wengenack NL, Razonable RR, Wilson JW. Mycobacterium wolinskyi: a case series and review of the literature. Diagn Microbiol Infect Dis. 2011 Dec; 71(4):421-7. Epub 2011 Sep 25.
    View PubMed
  229. Parsaik AK, Bhalla T, Dong M, Rostambeigi N, Dierkhising RA, Dean P, Abraham R, Prieto M, Kremers WK, Razonable RR, Kudva YC. Epidemiology of cytomegalovirus infection after pancreas transplantation. Transplantation. 2011 Nov 15; 92(9):1044-50.
    View PubMed
  230. Ariza-Heredia EJ, Razonable RR. Human herpes virus 8 in solid organ transplantation. Transplantation. 2011 Oct 27; 92 (8):837-44
    View PubMed
  231. Razonable RR. Antiviral drugs for viruses other than human immunodeficiency virus. Mayo Clin Proc. 2011 Oct; 86 (10):1009-26
    View PubMed
  232. Lee SO, Brown RA, Kang SH, Abdel Massih RC, Razonable RR. Toll-like receptor 4 polymorphisms and the risk of gram-negative bacterial infections after liver transplantation. Transplantation. 2011 Sep 27; 92(6):690-6.
    View PubMed
  233. Lee SO, Brown RA, Kang SH, Abdel-Massih RC, Razonable RR. Toll-like receptor 2 polymorphism and Gram-positive bacterial infections after liver transplantation. Liver Transpl. 2011 Sep; 17(9):1081-8.
    View PubMed
  234. Romero FA, Deziel PJ, Razonable RR. Majocchi's granuloma in solid organ transplant recipients. Transpl Infect Dis. 2011 Aug; 13(4):424-32. Epub 2011 Jan 27.
    View PubMed
  235. Lee SO, Brown RA, Razonable RR. Clinical significance of pretransplant chromosomally integrated human herpesvirus-6 in liver transplant recipients. Transplantation. 2011 Jul 27; 92(2):224-9.
    View PubMed
  236. El Helou OC, Berbari EF, Lahr BD, Marculescu CE, Razonable RR, Steckelberg JM, Hanssen AD, Osmon DR. Management of prosthetic joint infection treated with two-stage exchange: the impact of antimicrobial therapy duration. Curr. Orthop. Pract. 2011 Jul-Aug; 22(4):333-8.
  237. Lee SO, Brown RA, Eid AJ, Razonable RR. Chromosomally integrated human herpesvirus-6 in kidney transplant recipients. Nephrol Dial Transplant. 2011 Jul; 26(7):2391-3. Epub 2011 May 12.
    View PubMed
  238. Al-Hasan MN, Razonable RR, Kremers WK, Baddour LM. Impact of Gram-negative bloodstream infection on long-term allograft survival after kidney transplantation. Transplantation. 2011 Jun 15; 91(11):1206-10.
    View PubMed
  239. Lee SO, Kang SH, Abdel-Massih RC, Brown RA, Razonable RR. Spectrum of early-onset and late-onset bacteremias after liver transplantation: implications for management. Liver Transpl. 2011 Jun; 17 (6):733-41
    View PubMed
  240. Razonable RR. Management of viral infections in solid organ transplant recipients. Expert Rev Anti Infect Ther. 2011 Jun; 9 (6):685-700
    View PubMed
  241. Razonable RR, Findlay JY, O'Riordan A, Burroughs SG, Ghobrial RM, Agarwal B, Davenport A, Gropper M. Critical care issues in patients after liver transplantation. Liver Transpl. 2011 May; 17(5):511-27.
    View PubMed
  242. Romero FA, Razonable RR. Infections in liver transplant recipients. World J Hepatol. 2011 Apr 27; 3 (4):83-92
    View PubMed
  243. Wermers RA, Cooper K, Razonable RR, Deziel PJ, Whitford GM, Kremers WK, Moyer TP. Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy. Clin Infect Dis. 2011 Mar 1; 52(5):604-11. Epub 2011 Jan 16.
    View PubMed
  244. Hebart H, Lengerke C, Ljungman P, Paya CV, Klingebiel T, Loeffler J, Pfaffenrath S, Lewensohn-Fuchs I, Barkholt L, Tomiuk J, Meisner C, Lunenberg J, Top B, Razonable RR, Patel R, Litzow MR, Jahn G, Einsele H. Prospective comparison of PCR-based vs late mRNA-based preemptive antiviral therapy for HCMV infection in patients after allo-SCT. Bone Marrow Transplant. 2011 Mar; 46(3):408-15. Epub 2010 Jun 28.
    View PubMed
  245. El-Helou O, Berbari EF, Brown RA, Gralewski JH, Osmon DR, Razonable RR. Functional assessment of Toll-like receptor 2 and its relevance in patients with Staphylococcus aureus infection of joint prosthesis. Hum Immunol. 2011 Jan; 72(1):47-53. Epub 2010 Oct 28.
    View PubMed
  246. Ariza-Heredia E, Razonable RR. HHV-8 in solid organ transplantation. Transplantation .2011;27:(92):837-44.
  247. Razonable RR. Infections due to human herpesvirus 6 in solid organ transplant recipients. Curr Opin Organ Transplant. 2010 Dec; 15 (6):671-5
    View PubMed
  248. Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Munoz P, Kalil AC, Garcia-Diaz J, Orloff SL, House AA, Houston SH, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Fisher RA, Husain S, Wagener MM, Singh N, Cryptococcal Collaborative Transplant Study Group. Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients. Clin Infect Dis. 2010 Nov 1; 51(9):1062-9.
    View PubMed
  249. Osawa R, Alexander BD, Forrest GN, Lyon GM, Somani J, del Busto R, Pruett TL, Sifri CD, Limaye AP, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Kalil AC, Garcia-Diaz J, Orloff SL, Houston SH, Wray D, Huprikar S, Johnson LB, Razonable RR, Fisher RA, Wagener MM, Husain S, Singh N. Geographic differences in disease expression of cryptococcosis in solid organ transplant recipients in the United States. Ann Transplant. 2010 Oct-Dec; 15(4):77-83.
    View PubMed
  250. Lee SO, Razonable RR. Current concepts on cytomegalovirus infection after liver transplantation. World J Hepatol. 2010 Sep 27; 2 (9):325-36
    View PubMed
  251. Razonable RR, Lautenschlager I. Impact of human herpes virus 6 in liver transplantation. World J Hepatol. 2010 Sep 27; 2 (9):345-53
    View PubMed
  252. Boucher H, Miller LG, Razonable RR. Serious infections caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2010 Sep 15; 51 Suppl 2:S183-97.
    View PubMed
  253. Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, Del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Munoz P, Kalil AC, Garcia-Diaz J, Orloff SL, House AA, Houston SH, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Fisher RA, Husain S, Wagener MM, Singh N, Cryptococcal Collaborative Transplant Study Group. Cutaneous cryptococcosis in solid organ transplant recipients. Med Mycol. 2010 Sep; 48(6):785-91.
    View PubMed
  254. El Helou OC, Berbari EF, Lahr BD, Eckel-Passow JE, Razonable RR, Sia IG, Virk A, Walker RC, Steckelberg JM, Wilson WR, Hanssen AD, Osmon DR. Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention. Eur J Clin Microbiol Infect Dis. 2010 Aug; 29 (8):961-7 Epub 2010 May 27
    View PubMed
  255. Kumar D, Michaels MG, Morris MI, Green M, Avery RK, Liu C, Danziger-Isakov L, Stosor V, Estabrook M, Gantt S, Marr KA, Martin S, Silveira FP, Razonable RR, Allen UD, Levi ME, Lyon GM, Bell LE, Huprikar S, Patel G, Gregg KS, Pursell K, Helmersen D, Julian KG, Shiley K, Bono B, Dharnidharka VR, Alavi G, Kalpoe JS, Shoham S, Reid GE, Humar A, American Society of Transplantation H1N1 Collaborative Study Group. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis. 2010 Aug; 10(8):521-6. Epub 2010 Jul 09.
    View PubMed
  256. Razonable RR. Strategies for managing cytomegalovirus in transplant recipients. Expert Opin Pharmacother. 2010 Aug; 11(12):1983-97.
    View PubMed
  257. Brown RA, Razonable RR. A real-time PCR assay for the simultaneous detection of functional N284I and L412F polymorphisms in the human Toll-like receptor 3 gene. J Mol Diagn. 2010 Jul; 12 (4):493-7 Epub 2010 Apr 22
    View PubMed
  258. Boyce RD, Deziel PJ, Otley CC, Wilhelm MP, Eid AJ, Wengenack NL, Razonable RR. Phaeohyphomycosis due to Alternaria species in transplant recipients. Transpl Infect Dis. 2010 Jun; 12 (3):242-50 Epub 2009 Dec 09
    View PubMed
  259. Eid AJ, Razonable RR. New developments in the management of cytomegalovirus infection after solid organ transplantation. Drugs. 2010 May 28; 70(8):965-81.
    View PubMed
  260. Eid AJ, Brown RA, Arthurs SK, Lahr BD, Eckel-Passow JE, Larson TS, Razonable RR. A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection. Transpl Int. 2010 May 1; 23(5):506-13. Epub 2009 Nov 27.
    View PubMed
  261. Arthurs SK, Eid AJ, Deziel PJ, Marshall WF, Cassivi SD, Walker RC, Razonable RR. The impact of invasive fungal diseases on survival after lung transplantation. Clin Transplant. 2010 May-Jun; 24(3):341-8. Epub 2009 Aug 27.
    View PubMed
  262. Brown RA, Gralewski JH, Eid AJ, Knoll BM, Finberg RW, Razonable RR. R753Q single-nucleotide polymorphism impairs toll-like receptor 2 recognition of hepatitis C virus core and nonstructural 3 proteins. Transplantation. 2010 Apr 15; 89 (7):811-5
    View PubMed
  263. Osawa R, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, Del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Munoz P, Kalil AC, Garcia-Diaz J, Orloff S, House AA, Houston S, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Fisher RA, Husain S, Wagener MM, Singh N. Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis. Transplantation. 2010 Jan 15; 89(1):69-74.
    View PubMed
  264. Eid AJ, Arthurs SK, Deziel PJ, Wilhelm MP, Razonable RR. Clinical predictors of relapse after treatment of primary gastrointestinal cytomegalovirus disease in solid organ transplant recipients. Am J Transplant. 2010 Jan; 10 (1):157-61 Epub 2009 Nov 04
    View PubMed
  265. Razonable RR. Immune-based therapies for cytomegalovirus infection. Immunotherapy. 2010 Jan; 2(1):117-30.
    View PubMed
  266. Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Munoz P, Kalil AC, Garcia-Diaz J, Orloff S, House AA, Houston S, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Husain S, Singh N. Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. Clin Infect Dis. 2009 Dec 1; 49(11):1721-8.
    View PubMed
  267. Razonable RR, Eid AJ. Viral infections in transplant recipients. Minerva Med. 2009 Dec; 100 (6):479-501
    View PubMed
  268. Razonable RR, Zerr DM, AST Infectious Diseases Community of Practice. HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients. Am J Transplant. 2009 Dec; 9 Suppl 4:S97-100
    View PubMed
  269. Razonable RR, Zerr DM, AST Infectious Diseases Community of Practice. HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients. Am J Transplant. 2009 Dec; 9 Suppl 4:S100-3
    View PubMed
  270. Eid AJ, Brown RA, Hogan WJ, Lahr BD, Eckel-Passow JE, Litzow MR, Razonable RR. Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2009 Dec; 11(6):519-28. Epub 2009 Sep 09.
    View PubMed
  271. Brown RA, Gralewski JH, Razonable RR. The R753Q polymorphism abrogates toll-like receptor 2 signaling in response to human cytomegalovirus. Clin Infect Dis. 2009 Nov 1; 49 (9):e96-9
    View PubMed
  272. Abdel Massih RC, Razonable RR. Human herpesvirus 6 infections after liver transplantation. World J Gastroenterol. 2009 Jun 7; 15 (21):2561-9
    View PubMed
  273. Larson AN, Razonable RR, Hanssen AD. Capnocytophaga canimorsus a novel pathogen for joint arthroplasty. Clin Orthop Relat Res. 2009 Jun; 467 (6):1634-8 Epub 2008 Dec 09
    View PubMed
  274. Razonable RR. Cytomegalovirus infection in solid organ transplant recipients. Johns Hopkins eTransplant ID Review.. 2009 Jun;
  275. Al-Hasan MN, Razonable RR, Eckel-Passow JE, Baddour LM. Incidence rate and outcome of Gram-negative bloodstream infection in solid organ transplant recipients. Am J Transplant. 2009 Apr; 9(4):835-43.
    View PubMed
  276. Cummins NW, Deziel PJ, Abraham RS, Razonable RR. Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation. Transpl Infect Dis. 2009 Feb; 11(1):20-7. Epub 2008 Sep 21.
    View PubMed
  277. Razonable RR. Management of cytomegalovirus infection after renal transplantation. IDCP. 2009; 17(4):220-30.
  278. Razonable RR, Pulido JS, Deziel PJ, Dev S, Salomao DR, Walker RC. Chorioretinitis and vitreitis due to Tropheryma whipplei after transplantation: case report and review. Transpl Infect Dis. 2008 Dec; 10 (6):413-8 Epub 2008 June 18
    View PubMed
  279. Pandian TK, Deziel PJ, Otley CC, Eid AJ, Razonable RR. Mycobacterium marinum infections in transplant recipients: case report and review of the literature. Transpl Infect Dis. 2008 Oct; 10(5):358-63. Epub 2008 May 15.
    View PubMed
  280. El Helou OC, Berbari EF, Marculescu CE, El Atrouni WI, Razonable RR, Steckelberg JM, Hanssen AD, Osmon DR. Outcome of enterococcal prosthetic joint infection: is combination systemic therapy superior to monotherapy? Clin Infect Dis. 2008 Oct 1; 47(7):903-9.
    View PubMed
  281. Arthurs SK, Eid AJ, Pedersen RA, Kremers WK, Cosio FG, Patel R, Razonable RR. Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis. 2008 Mar 15; 46 (6):840-6
    View PubMed
  282. Eid AJ, Arthurs SK, Deziel PJ, Wilhelm MP, Razonable RR. Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes. Clin Transplant. 2008 Mar-Apr; 22 (2):162-70
    View PubMed
  283. Eid AJ, Bakri SJ, Kijpittayarit S, Razonable RR. Clinical features and outcomes of cytomegalovirus retinitis after transplantation. Transpl Infect Dis. 2008 Feb; 10 (1):13-8 Epub 2007 May 19
    View PubMed
  284. Eid AJ, Paya CV, Razonable RR. Optimal length of valganciclovir prophylaxis after solid organ transplantation. Trends in Transplantation. 2008; 2(2):92-100.
  285. Cascalho M, Ogle BM, Razonable RR, West LJ, Platt JL. Cardiac transplantation in infancy: A model for dissecting immunological function. Paediatr Child Health. 2008; 18(Suppl 1):S30-S32.
  286. Pandian TK, Razonable RR. Bidirectional interaction between cytomegalovirus and hepatitis C virus after liver transplantation: A critical review of the clinical evidence. Trends in Transplantation. 2008; 3:35-43.
  287. Arthurs SK, Eid AJ, Pedersen RA, Dierkhising RA, Kremers WK, Patel R, Razonable RR. Delayed-onset primary cytomegalovirus disease after liver transplantation. Liver Transpl. 2007 Dec; 13 (12):1703-9
    View PubMed
  288. Eid AJ, Razonable RR. Cytomegalovirus disease in solid organ transplant recipients: advances lead to new challenges and opportunities. Curr Opin Organ Transplant. 2007 Dec; 12(6):610-7.
  289. Kijpittayarit-Arthurs S, Eid AJ, Kremers WK, Pedersen RA, Dierkhising RA, Patel R, Razonable RR. Clinical features and outcomes of delayed-onset primary cytomegalovirus disease in cardiac transplant recipients. J Heart Lung Transplant. 2007 Oct; 26 (10):1019-24
    View PubMed
  290. Humar A, Washburn K, Freeman R, Paya CV, Mouas H, Alecock E, Razonable RR, PV16000 Study Group. An assessment of interactions between hepatitis C virus and herpesvirus reactivation in liver transplant recipients using molecular surveillance. Liver Transpl. 2007 Oct; 13(10):1422-7.
    View PubMed
  291. Eid AJ, Berbari EF, Sia IG, Wengenack NL, Osmon DR, Razonable RR. Prosthetic joint infection due to rapidly growing mycobacteria: report of 8 cases and review of the literature. Clin Infect Dis. 2007 Sep 15; 45(6):687-94. Epub 2007 Aug 13.
    View PubMed
  292. Eid AJ, Davis MD, Bingham LG, Kalaaji AN, Enzler M, Razonable RR, Berbari EF. A young man with pyomyositis and bullous disease. Clin Infect Dis. 2007 Sep 15; 45(6):741, 799-800.
    View PubMed
  293. Eid AJ, Brown RA, Paya CV, Razonable RR. Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus. Transplantation. 2007 Aug 27; 84 (4):511-6
    View PubMed
  294. Eid AJ, Razonable RR. Valganciclovir for the treatment of cytomegalovirus retinitis in patients with AIDS. Expert Review of Ophthalmology. 2007 Jun; 2(3):351-61.
  295. Bonatti H, Sawyer R, Dickson RC, Razonable R, Schmitt T, Mendez J, Singh N, Pruett T. Transmission of viral disease to the recipient through the donor liver. Current Opinion in Organ Transplantation. 2007 Jun; 12(3):231-41.
  296. Kijpittayarit S, Eid AJ, Brown RA, Paya CV, Razonable RR. Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Clin Infect Dis. 2007 May 15; 44(10):1315-20.
    View PubMed
  297. Kijpittayarit S, Razonable RR. JC virus infection after transplantation: Beyond the classic progressive multifocal leukoencephalopathy? Gastroenterol Hepatol. 2007 Jan; 3(1):74-6.
  298. Assi MA, Pulido JS, Peters SG, McCannel CA, Razonable RR. Graft-vs.-host disease in lung and other solid organ transplant recipients. Clin Transplant. 2007 Jan-Feb; 21(1):1-6.
    View PubMed
  299. Anaissie EJ, Segal BH, Graybill JR, Arndt C, Perfect JR, Kleinberg M, Pappas P, Benjamin D, Rubin R, Aberg JA, Adderson EE, Adler-Shohet FC, Akan H, Akova M, Almyroudis NG, Alexander BD, Andes D, Arrieta A, Baddley JW, Barron MA, Belzberg H, Boucher HW, Boyce TG, Casadevall A, Chandrasekar PH, Cleary JD, Cordonnier C, Cornely OA, Cuenca-Estrella M, Daly JS, Daoura N, Denning DW, dePauw B, de Repentigny L, Dignani MC, Dismukes WE, Donnelly JP, Donowitz GR, Dupont B, Drusano G, Ellis M, Espinel-Ingroff A, Fishman JA, Fleming R, Forrest G, Ghannoum M, Goldman M, Grazziutti M, Greene JN, Greenberg RN, Gubbins PO, Hadley S, Herbrecht R, Hiemenz JW, Hope W, Hospenthal DR, Husain S, Ito JI, Jacobson RM, Johnson M, Keating MR, Kett DH, Knapp K, Kontoyiannis DP, Krcmery VC, Larsen R, Laverdiere M, Ljungman P, Lortholary O, Maertens J, Marriott D, Mattiuzzi G, McGinnis MR, Morris M, Nucci M, Odds FC, Pankey GA, Patterson T, Pfaller M, Razonable RR, Reboli AC, Rinaldi MG, Roberts GD, Rodriguez Tudela JL, Rotstein C, Ruhnke M, Schuster M, Shoham S, Sia IG, Siebel N, Silviera F, Singh N, Sobel J, Solomkin JS, Sorrell TC, Steinbach WJ, Temesgen Z, Tortorano A, Vartivarian S, VerWeij P, Viscoli C, Viviani MA, Walker RC, Wheat JL, Wiley J, Williamson P, Wingard JR, Yu VL, Zaoutis T. Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt. Clin Infect Dis. 2006 Oct 15; 43(8):1031-9. Epub 2006 Sep 13.
    View PubMed
  300. Eid AJ, Brown RA, Patel R, Razonable RR. Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis. 2006 Jul 1; 43 (1):40-8 Epub 2006 May 12
    View PubMed
  301. Razonable RR, Henault M, Paya CV. Stimulation of toll-like receptor 2 with bleomycin results in cellular activation and secretion of pro-inflammatory cytokines and chemokines. Toxicol Appl Pharmacol. 2006 Feb 1; 210 (3):181-9 Epub 2005 June 17
    View PubMed
  302. Ogle BM, West LJ, Driscoll DJ, Strome SE, Razonable RR, Paya CV, Cascalho M, Platt JL. Effacing of the T cell compartment by cardiac transplantation in infancy. J Immunol. 2006 Feb 1; 176 (3):1962-7
    View PubMed
  303. Razonable RR, Brown RA, Humar A, Covington E, Alecock E, Paya CV. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease. J Infect Dis. 2005 Oct 15; 192(8):1331-9.
    View PubMed
  304. Razonable RR, Brown RA, Humar A, Covington E, Alecock E, Paya CV. A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients. J Infect Dis. 2005 Oct 15; 192(8):1349-54.
    View PubMed
  305. Humar A, Kumar D, Mazzulli T, Razonable RR, Moussa G, Paya CV, Covington E, Alecock E, Pescovitz MD. A surveillance study of adenovirus infection in adult solid organ transplant recipients. Am J Transplant. 2005 Oct; 5(10):2555-9.
    View PubMed
  306. Razonable RR, Henault M, Watson HL, Paya CV. Nystatin induces secretion of interleukin (IL)-1beta, IL-8, and tumor necrosis factor alpha by a toll-like receptor-dependent mechanism. Antimicrob Agents Chemother. 2005 Aug; 49 (8):3546-9
    View PubMed
  307. Humar A, Mazzulli T, Moussa G, Razonable RR, Paya CV, Pescovitz MD, Covington E, Alecock E. Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients. Am J Transplant. 2005 May; 5(5):1065-70.
    View PubMed
  308. Razonable RR, Henault M, Lee LN, Laethem C, Johnston PA, Watson HL, Paya CV. Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of toll-like receptors 1 and 2. Antimicrob Agents Chemother. 2005 Apr; 49 (4):1617-21
    View PubMed
  309. Razonable RR, Emery VC, 11th Annual Meeting of the IHMF (International Herpes Management Forum). Management of CMV infection and disease in transplant patients. 27-29 February 2004. Herpes. 2004 Dec; 11(3):77-86.
    View PubMed
  310. Razonable RR, Osmon DR, Steckelberg JM. Linezolid therapy for orthopedic infections. Mayo Clin Proc. 2004 Sep; 79(9):1137-44.
    View PubMed
  311. Razonable RR, Paya CV. Valganciclovir for the prevention and treatment of cytomegalovirus disease in immunocompromised hosts. Expert Rev Anti Infect Ther. 2004 Feb; 2 (1):27-41
    View PubMed
  312. Razonable RR, Paya CV. Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections. Herpes. 2003 Dec; 10(3):60-5.
    View PubMed
  313. Razonable RR, Rahman AE, Wilson WR. Lemierre syndrome variant: necrobacillosis associated with inferior vena cava thrombosis and pulmonary abscesses after trauma-induced leg abscess. Mayo Clin Proc. 2003 Sep; 78 (9):1153-6
    View PubMed
  314. Razonable RR, van Cruijsen H, Brown RA, Wilson JA, Harmsen WS, Wiesner RH, Smith TF, Paya CV. Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir. J Infect Dis. 2003 Jun 1; 187(11):1801-8. Epub 2003 May 09.
    View PubMed
  315. Razonable RR, Rivero A, Brown RA, Hart GD, Espy MJ, van Cruijsen H, Wilson J, Groettum C, Kremers W, Smith TF, Paya CV. Detection of simultaneous beta-herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection. Clin Transplant. 2003 Apr; 17 (2):114-20
    View PubMed
  316. Feldstein AE, Razonable RR, Boyce TG, Freese DK, El-Youssef M, Perrault J, Paya CV, Ishitani MB. Prevalence and clinical significance of human herpesviruses 6 and 7 active infection in pediatric liver transplant patients. Pediatr Transplant. 2003 Apr; 7 (2):125-9
    View PubMed
  317. Razonable RR, Burak KW, van Cruijsen H, Brown RA, Charlton MR, Smith TF, Espy MJ, Kremers W, Wilson JA, Groettum C, Wiesner R, Paya CV. The pathogenesis of hepatitis C virus is influenced by cytomegalovirus. Clin Infect Dis. 2002 Oct 15; 35(8):974-81.
    View PubMed
  318. Razonable RR, Paya CV. beta-Herpesviruses in transplantation. Reviews in Medical Microbiology. 2002 Oct; 13(4):163-76.
  319. Razonable RR, Paya CV. The impact of human herpesvirus-6 and-7 infection on the outcome of liver transplantation. Liver Transpl. 2002 Aug; 8(8):651-8.
    View PubMed
  320. Razonable RR, Litzow MR, Khaliq Y, Piper KE, Rouse MS, Patel R. Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis. Clin Infect Dis. 2002 Jun 1; 34 (11):1469-74 Epub 2002 May 07
    View PubMed
  321. Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, Paya CV, Charlton MR. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl. 2002 Apr; 8 (4):362-9
    View PubMed
  322. Razonable RR, Brown RA, Wilson J, Groettum C, Kremers W, Espy M, Smith TF, Paya CV. The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. Transplantation. 2002 Mar 27; 73 (6):968-73
    View PubMed
  323. Razonable RR, Paya CV, Smith TF. Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients. J Clin Microbiol. 2002 Mar; 40 (3):746-52
    View PubMed
  324. Razonable RR, Fanning C, Brown RA, Espy MJ, Rivero A, Wilson J, Kremers W, Smith TF, Paya CV. Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts. J Infect Dis. 2002 Jan 1; 185(1):110-3. Epub 2001 Dec 14.
    View PubMed
  325. Razonable RR, Paya CV. Fungal infections in liver transplantation: Prophylaxis, surveillance, and treatment. Current Opinion in Organ Transplantation. 2002; 7(2):137-43.
  326. Razonable RR, Brown RA, Espy MJ, Rivero A, Kremers W, Wilson J, Groettum C, Smith TF, Paya CV. Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems. J Clin Microbiol. 2001 Dec; 39 (12):4472-6
    View PubMed
  327. Razonable RR, Rivero A, Rodriguez A, Wilson J, Daniels J, Jenkins G, Larson T, Hellinger WC, Spivey JR, Paya CV. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. J Infect Dis. 2001 Dec 1; 184(11):1461-4. Epub 2001 Oct 23.
    View PubMed
  328. Razonable RR, Aksamit AJ, Wright AJ, Wilson JW. Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy. Mayo Clin Proc. 2001 Nov; 76 (11):1171-5
    View PubMed
  329. Razonable RR, Lewallen DG, Patel R, Osmon DR. Vertebral osteomyelitis and prosthetic joint infection due to Staphylococcus simulans. Mayo Clin Proc. 2001 Oct; 76(10):1067-70.
    View PubMed
  330. Razonable RR, Patel R, Wilhelm MP, Gertz MA, Litzow MR, Inwards DJ, Dearani JA, Edwards BS, McGregor CG. Fatal disseminated aspergillosis following sequential heart and stem cell transplantation for systemic amyloidosis. Am J Transplant. 2001 May; 1 (1):93-5
    View PubMed
PST-20223091